Autonomic Nervous System 12

Atropine

Non-selective muscarinic antagonist
1 ยท Mechanism
Competitively blocks muscarinic (M1-M4) receptors at parasympathetic effector organs, with little effect on nicotinic receptors.
2 ยท Adverse effect
Toxicity mnemonic: blind as a bat (mydriasis), dry as a bone, mad as a hatter (delirium), red as a beet, hot as a hare - plus urinary retention and tachycardia.
3 ยท Contraindications
Angle-closure glaucoma and mechanical GI or urinary obstruction; caution in benign prostatic hypertrophy and the elderly.
4 ยท Indication
Symptomatic bradycardia and the muscarinic effects of organophosphate poisoning (given with pralidoxime).

Scopolamine

Muscarinic antagonist (tertiary amine, crosses BBB)
1 ยท Mechanism
Non-selective muscarinic antagonist that readily penetrates the blood-brain barrier, unlike quaternary anticholinergics.
2 ยท Adverse effect
Marked sedation, amnesia, confusion and hallucinations; dry mouth, blurred vision and urinary retention; patch causes contact dermatitis.
3 ยท Contraindications
Angle-closure glaucoma and mechanical GI/GU obstruction; avoid in elderly patients and cognitive impairment (delirium risk).
4 ยท Indication
Motion sickness (transdermal patch) and prevention of postoperative nausea and vomiting.

Pilocarpine

Direct-acting muscarinic agonist
1 ยท Mechanism
Direct M3 agonist that contracts the ciliary muscle and sphincter pupillae, opening trabecular meshwork outflow and lowering intraocular pressure.
2 ยท Adverse effect
Brow ache, blurred near vision and miosis; systemic muscarinic effects - sweating, salivation, bradycardia, bronchoconstriction and diarrhoea.
3 ยท Contraindications
Uncontrolled bronchial asthma or COPD, active peptic ulcer disease, and untreated cardiovascular disease (muscarinic load).
4 ยท Indication
Glaucoma (topical, especially acute angle-closure) and xerostomia in Sjogren syndrome (oral).

Bethanechol

Muscarinic agonist resistant to acetylcholinesterase
1 ยท Mechanism
Direct-acting M3 agonist that is not hydrolysed by acetylcholinesterase, acting preferentially on bladder detrusor and GI smooth muscle.
2 ยท Adverse effect
Abdominal cramps, salivation, nausea, diarrhoea, sweating, bradycardia and hypotension from muscarinic excess.
3 ยท Contraindications
Bronchial asthma, peptic ulcer disease, mechanical obstruction of the bladder or bowel, and hyperthyroidism.
4 ยท Indication
Postoperative and neurogenic urinary retention and paralytic ileus.

Neostigmine

Reversible acetylcholinesterase inhibitor (quaternary)
1 ยท Mechanism
Quaternary acetylcholinesterase inhibitor that accumulates acetylcholine at the neuromuscular junction; too polar to enter the CNS.
2 ยท Adverse effect
SLUDGE effects (salivation, lacrimation, urination, defecation, GI upset, emesis), fasciculations, bradycardia; excess causes cholinergic crisis.
3 ยท Contraindications
Mechanical GI or urinary obstruction; caution in asthma and bradyarrhythmias - muscarinic effects are reversed by atropine.
4 ยท Indication
Reversal of neuromuscular blockade after surgery, myasthenia gravis, and postoperative ileus or urinary retention.

Physostigmine

Tertiary amine acetylcholinesterase inhibitor
1 ยท Mechanism
Lipophilic tertiary amine that crosses the blood-brain barrier, restoring central cholinergic tone in anticholinergic delirium.
2 ยท Adverse effect
Muscarinic effects plus central effects - drowsiness, confusion and seizures in overdose; miosis and bradycardia.
3 ยท Contraindications
Mechanical GI/GU obstruction, bronchial asthma and cardiovascular disease; must be given slowly IV (seizure risk).
4 ยท Indication
Antidote for central anticholinergic (atropine or tricyclic) toxicity; historically used topically in glaucoma.

Pyridostigmine

Long-acting reversible acetylcholinesterase inhibitor
1 ยท Mechanism
Slowly acting acetylcholinesterase inhibitor with a longer duration than neostigmine, raising acetylcholine at the motor end plate.
2 ยท Adverse effect
Muscarinic effects (cramps, diarrhoea, salivation), fasciculations, and weakness with overdosage (cholinergic crisis).
3 ยท Contraindications
Mechanical bowel or bladder obstruction; caution in asthma and cardiac conduction disease.
4 ยท Indication
Maintenance therapy of myasthenia gravis and reversal of neuromuscular blockade.

Pralidoxime

Acetylcholinesterase reactivator (oxime)
1 ยท Mechanism
Oxime group cleaves the enzyme-pesticide bond, reactivating acetylcholinesterase alkylated by organophosphates - but only before the complex ages.
2 ยท Adverse effect
Dizziness, headache, tachycardia, hypertension, nausea; rapid IV injection can cause neuromuscular weakness and apnoea.
3 ยท Contraindications
Useless once ageing is complete (hours for most organophosphates); caution in myasthenia gravis and renal failure.
4 ยท Indication
Organophosphate poisoning, given alongside atropine (atropine covers muscarinic symptoms, oxime restores the enzyme).

Tropicamide

Short-acting muscarinic mydriatic and cycloplegic
1 ยท Mechanism
Briefly blocks muscarinic receptors in the sphincter pupillae and ciliary muscle, producing dilation and paralysis of accommodation.
2 ยท Adverse effect
Transient stinging, blurred near vision, photophobia and a brief rise in intraocular pressure.
3 ยท Contraindications
Angle-closure glaucoma or a history of angle-closure attack.
4 ยท Indication
Mydriasis for fundus examination and refraction - the shortest-acting mydriatic in routine use.

Phenylephrine

Selective alpha-1 adrenergic agonist
1 ยท Mechanism
Direct selective alpha-1 agonist causing arterial and venous vasoconstriction with no beta activity.
2 ยท Adverse effect
Reflex bradycardia, hypertension, reduced renal perfusion, and tissue necrosis if it extravasates from an IV line; topical use causes rebound congestion.
3 ยท Contraindications
Severe hypertension, MAOI therapy, severe coronary artery disease and closed-angle glaucoma (caution).
4 ยท Indication
Hypotension and shock (IV infusion), nasal decongestion (topical), and mydriasis without cycloplegia (ophthalmic).

Isoprenaline

Non-selective beta-adrenergic agonist
1 ยท Mechanism
Potent beta-1 and beta-2 agonist with no alpha action - raises heart rate and contractility while relaxing bronchial and vascular smooth muscle.
2 ยท Adverse effect
Tachycardia, palpitations, arrhythmias, tremor, hypotension and worsening of angina.
3 ยท Contraindications
Tachyarrhythmias, ischaemic heart disease and hyperthyroidism (exaggerated response).
4 ยท Indication
Symptomatic bradycardia when atropine or pacing is unavailable; obsolete for asthma (superseded by selective beta-2 agonists).

Methacholine

Rapidly hydrolysed muscarinic agonist
1 ยท Mechanism
Choline ester that stimulates M3 receptors on airway smooth muscle, provoking bronchoconstriction before acetylcholinesterase destroys it.
2 ยท Adverse effect
Bronchospasm and wheeze during challenge, plus salivation, bradycardia and hypotension if systemic effects appear.
3 ยท Contraindications
Severe asthma, significant cardiac or respiratory disease, and recent myocardial infarction.
4 ยท Indication
Methacholine challenge test to confirm airway hyper-responsiveness when spirometry in suspected asthma is normal.

Analgesics & Anesthetics 20

Morphine

Full mu-opioid receptor agonist
1 ยท Mechanism
Full mu-opioid agonist (Gi/Go coupled): opens K+ channels and inhibits adenylyl cyclase, hyperpolarising neurons and damping pain transmission.
2 ยท Adverse effect
Respiratory depression, constipation, nausea, miosis, urinary retention, histamine release (hypotension, bronchospasm) and dependence.
3 ยท Contraindications
Coma, head injury with raised intracranial pressure, paralytic ileus and acute bronchial asthma; caution in renal failure and the elderly.
4 ยท Indication
Severe pain (postoperative, cancer, myocardial infarction) and acute pulmonary oedema (IV drip alongside nitrates).

Fentanyl

Ultra-potent mu-opioid agonist
1 ยท Mechanism
Highly lipid-soluble mu agonist, roughly 100 times more potent than morphine, with rapid CNS entry and fast redistribution.
2 ยท Adverse effect
Rapid-onset severe respiratory depression, chest wall rigidity after fast IV bolus, bradycardia, nausea and postoperative delirium in the elderly.
3 ยท Contraindications
Same cautions as morphine; extreme caution combining with benzodiazepines or alcohol (respiratory arrest), and with CYP3A4 inhibitors.
4 ยท Indication
Intraoperative analgesia, severe acute pain, and transdermal patches for chronic cancer pain.

Tramadol

Weak opioid plus SNRI-type analgesic
1 ยท Mechanism
Dual mechanism: weak mu-opioid receptor agonism plus inhibition of noradrenaline and serotonin reuptake in descending pathways.
2 ยท Adverse effect
Lowers the seizure threshold (can precipitate fits), serotonin syndrome when combined with SSRIs/MAOIs, plus nausea, dizziness and constipation.
3 ยท Contraindications
Epilepsy, concurrent serotonergic drugs (SSRIs, MAOIs, triptans) and untreated alcohol or sedative withdrawal.
4 ยท Indication
Moderate pain not controlled by simple analgesics, and some neuropathic pain.

Naloxone

Opioid receptor antagonist
1 ยท Mechanism
Competitive antagonist at mu, kappa and delta opioid receptors with no agonist activity, displacing opioids and reversing respiratory depression.
2 ยท Adverse effect
Precipitates abrupt withdrawal in opioid-dependent patients (agitation, vomiting, pain, tachycardia); short duration allows re-sedation.
3 ยท Contraindications
No absolute contraindication, but expect violent withdrawal in dependent patients and caution in neonates.
4 ยท Indication
Emergency reversal of opioid-induced respiratory depression and coma in overdose.

Codeine

Opioid prodrug (CYP2D6 substrate)
1 ยท Mechanism
Prodrug converted to morphine by CYP2D6, with additional direct suppression of the medullary cough centre via mu receptors.
2 ยท Adverse effect
Constipation, nausea and drowsiness; ultra-rapid CYP2D6 metabolisers get toxicity and life-threatening respiratory depression.
3 ยท Contraindications
Children under 12 and after tonsillectomy or adenoidectomy (FDA/EMA boxed warnings), and known ultra-rapid metabolisers.
4 ยท Indication
Mild to moderate pain (often paired with paracetamol) and suppression of distressing dry cough.

Methadone

Long-acting mu-opioid agonist
1 ยท Mechanism
Long-acting mu agonist that also blocks NMDA receptors and inhibits monoamine reuptake; accumulates during induction.
2 ยท Adverse effect
QT prolongation and torsades de pointes, delayed respiratory depression, sedation, constipation and dependence.
3 ยท Contraindications
Known long-QT syndrome or concurrent QT-prolonging drugs, strong CYP3A4 inhibitors, and benzodiazepine or alcohol co-use.
4 ยท Indication
Maintenance treatment of opioid use disorder and chronic pain (dosing is titrated slowly because of accumulation).

Buprenorphine

Partial mu-opioid agonist / kappa antagonist
1 ยท Mechanism
High-affinity partial mu agonist with a ceiling effect on respiratory depression, plus kappa antagonism.
2 ยท Adverse effect
Precipitated withdrawal if given to full-agonist users too early, constipation, sedation, nausea, and hepatic injury with IV misuse.
3 ยท Contraindications
Must not be started while full agonists are active without supervision; boxed warning with benzodiazepines; caution in respiratory and hepatic disease.
4 ยท Indication
Opioid use disorder (sublingual, often with naloxone) and moderate to severe pain.

Aspirin

Irreversible COX-1/COX-2 inhibitor (antiplatelet analgesic)
1 ยท Mechanism
Irreversibly acetylates cyclooxygenase, abolishing thromboxane A2 in platelets for their whole 7-10 day lifespan and reducing prostaglandins in tissues.
2 ยท Adverse effect
GI ulceration and bleeding, tinnitus at high doses, impaired haemostasis, aspirin-exacerbated respiratory disease, and Reye syndrome in children with viral fever.
3 ยท Contraindications
Children or teenagers with viral illness (Reye syndrome), third trimester of pregnancy, active peptic ulcer and bleeding disorders.
4 ยท Indication
Chewed loading dose in acute myocardial infarction, secondary prevention of stroke, and anti-inflammatory treatment in rheumatic conditions.

Paracetamol

Central analgesic and antipyretic
1 ยท Mechanism
Weak central cyclooxygenase inhibitor with minimal peripheral action - probably also works through central serotonergic descending pathways.
2 ยท Adverse effect
Overdose causes hepatotoxicity via the reactive metabolite NAPQI once glutathione is depleted; no ulcer or platelet effect at normal doses.
3 ยท Contraindications
Severe hepatic impairment and chronic alcohol misuse or fasting (glutathione depletion raises toxicity risk).
4 ยท Indication
Fever and mild to moderate pain - the preferred analgesic when NSAIDs are contraindicated (ulcer disease, pregnancy, renal disease).

Ibuprofen

Reversible COX-1/COX-2 inhibitor (NSAID)
1 ยท Mechanism
Reversibly inhibits COX-1 and COX-2, reducing prostaglandin synthesis in inflamed tissue, platelets, gastric mucosa and the kidney.
2 ยท Adverse effect
Gastric ulceration and bleeding, sodium and water retention with renal impairment, raised blood pressure, and cardiovascular risk on chronic use.
3 ยท Contraindications
Active peptic ulcer, severe renal impairment, third trimester of pregnancy (premature ductus closure), post-CABG, and aspirin-sensitive asthma.
4 ยท Indication
Pain and inflammation (dental, musculoskeletal, dysmenorrhoea) and fever in children.

Celecoxib

Selective COX-2 inhibitor (coxib)
1 ยท Mechanism
Selectively inhibits the inducible COX-2 isoform while sparing platelet COX-1, so prostaglandins drop in inflamed tissue without blocking thromboxane.
2 ยท Adverse effect
Thrombotic cardiovascular events with chronic high doses, hypertension and renal impairment; cross-reactivity in sulfonamide allergy.
3 ยท Contraindications
Sulfonamide hypersensitivity, established ischaemic heart or cerebrovascular disease (caution), and any use after CABG surgery.
4 ยท Indication
Osteoarthritis and rheumatoid arthritis in patients at high risk of GI bleeding from conventional NSAIDs.

Colchicine

Antimicrotubular anti-inflammatory (gout)
1 ยท Mechanism
Binds tubulin and stops microtubule polymerisation, blocking neutrophil migration and NLRP3 inflammasome activation in the acutely inflamed joint.
2 ยท Adverse effect
Dose-limiting diarrhoea and cramping, nausea; overdose causes bone marrow suppression and myoneuropathy - very narrow therapeutic index.
3 ยท Contraindications
Severe renal or hepatic impairment, and strong CYP3A4 or P-gp inhibitors (clarithromycin, statins) that spike levels dangerously.
4 ยท Indication
Acute gout flare (started immediately with an anti-inflammatory) and familial Mediterranean fever.

Ketamine

Dissociative anaesthetic (NMDA antagonist)
1 ยท Mechanism
Non-competitive NMDA glutamate receptor antagonist producing dissociative anaesthesia, with added catecholamine reuptake inhibition.
2 ยท Adverse effect
Emergence hallucinations and nightmares, hypersalivation, laryngospasm, nystagmus, and a transient rise in blood pressure and heart rate.
3 ยท Contraindications
Caution in head injury with raised intracranial pressure, uncontrolled hypertension, ischaemic heart disease and active psychosis.
4 ยท Indication
Induction of anaesthesia and procedural sedation - favoured in hypotensive and asthmatic patients (it also bronchodilates).

Propofol

Intravenous hypnotic (GABA-A modulator)
1 ยท Mechanism
Potentiates GABA-A (and glycine) receptor chloride currents, giving rapid hypnosis with exceptionally fast offset.
2 ยท Adverse effect
Hypotension from vasodilation, apnoea and respiratory depression, pain on injection, and propofol infusion syndrome (rhabdomyolysis, acidosis, hypertriglyceridaemia) on prolonged high-dose infusion.
3 ยท Contraindications
Egg or soy hypersensitivity (lipid emulsion, relative), severe haemodynamic instability, and prolonged high-dose infusion in children is avoided.
4 ยท Indication
Induction and maintenance of anaesthesia, ICU sedation, and procedural sedation.

Thiopental

Ultra-short-acting barbiturate
1 ยท Mechanism
Positive allosteric modulator at GABA-A receptors that lengthens chloride channel opening, causing rapid CNS depression then redistribution.
2 ยท Adverse effect
Dose-dependent respiratory and cardiovascular depression, laryngospasm, extravasation necrosis, and enzyme induction with repeated doses.
3 ยท Contraindications
Absolute contraindication in hepatic porphyrias (strongly porphyrogenic); caution in severe asthma, hypotension and myxoedema.
4 ยท Indication
Rapid induction of anaesthesia, historical barbiturate coma for cerebral protection.

Midazolam

Short-acting benzodiazepine
1 ยท Mechanism
Imidazobenzodiazepine that increases the frequency of GABA-A chloride channel opening, producing sedation, amnesia and anxiolysis.
2 ยท Adverse effect
Respiratory depression (sharply potentiated by opioids), anterograde amnesia, paradoxical agitation and hiccups, and dependence with prolonged use.
3 ยท Contraindications
Severe respiratory failure or obstructive sleep apnoea, opioid co-sedation without monitoring, and caution in acute narrow-angle glaucoma.
4 ยท Indication
Status epilepticus (IV, IM or buccal), procedural sedation and premedication before anaesthesia - reversed by flumazenil.

Lidocaine

Amide local anesthetic; class Ib antiarrhythmic
1 ยท Mechanism
Blocks voltage-gated sodium channels in a use-dependent way, preventing depolarisation in fast-firing nerves and ischaemic ventricular tissue.
2 ยท Adverse effect
Early CNS toxicity (perioral numbness, tinnitus, confusion) progressing to seizures; cardiac toxicity causes hypotension, bradycardia and arrhythmias.
3 ยท Contraindications
Complete heart block or severe bradycardia (it depresses conduction) and hypersensitivity to amide local anesthetics.
4 ยท Indication
Local anaesthesia (infiltration, nerve block) and ventricular arrhythmias, especially post-myocardial infarction.

Bupivacaine

Long-acting amide local anesthetic
1 ยท Mechanism
Prolongs inactivated-state sodium channel blockade in sensory and motor nerves, with long duration from high protein binding.
2 ยท Adverse effect
The most cardiotoxic local anesthetic - inadvertent IV use can trigger refractory arrhythmias and cardiac arrest; CNS toxicity follows.
3 ยท Contraindications
Intravascular injection is absolute; caution in acidosis and hypoalbuminaemia, which raise the free (toxic) drug fraction.
4 ยท Indication
Epidural, spinal and peripheral nerve blocks, including labour analgesia and long surgical procedures.

Succinylcholine

Depolarising neuromuscular blocker
1 ยท Mechanism
A persistent acetylcholine agonist at the motor end plate - sustained depolarisation first fasciculates then paralyses the muscle; plasma cholinesterase breaks it down in minutes.
2 ยท Adverse effect
Hyperkalaemic cardiac arrest in denervation states, masseter spasm and malignant hyperthermia trigger, childhood bradycardia, fasciculations with post-operative myalgia, and apnoea in pseudocholinesterase deficiency.
3 ยท Contraindications
Personal or family history of malignant hyperthermia, burns or injuries older than 24-48 hours, prolonged immobilisation or denervation (upregulated receptors - hyperkalaemia), and known pseudocholinesterase deficiency.
4 ยท Indication
Rapid-sequence induction and intubation - onset within a minute and duration under 10 minutes, the classic choose-for-speed paralyser.

Sevoflurane

Volatile inhalational anaesthetic
1 ยท Mechanism
Potentiates GABA-A and glycine receptors and blocks NMDA channels - soft-smelling, low blood-gas solubility agent with fast induction and emergence.
2 ยท Adverse effect
Nausea and vomiting, emergence agitation in children, respiratory depression, rare compound A formation with CO2 absorbents, and triggering of malignant hyperthermia.
3 ยท Contraindications
Known malignant hyperthermia susceptibility (use total intravenous anaesthesia instead) and caution in severe hepatic disease.
4 ยท Indication
Induction and maintenance of general anaesthesia in adults and children - the preferred volatile agent when a smooth inhalational induction is wanted.

CNS & Psychopharmacology 28

Phenytoin

Hydantoin anticonvulsant (sodium channel blocker)
1 ยท Mechanism
Use-dependent block of voltage-gated sodium channels, prolonging their inactivated state and limiting high-frequency seizure discharge spread.
2 ยท Adverse effect
Gingival hyperplasia, nystagmus and cerebellar ataxia, hirsutism, megaloblastic anaemia, enzyme induction (vitamin D and folate depletion), and SJS in HLA-B*15:02 carriers.
3 ยท Contraindications
Previous aromatic anticonvulsant rash (SJS/TEN), sinus bradycardia or Adams-Stokes attacks for IV use, and hypersensitivity.
4 ยท Indication
Generalised tonic-clonic seizures and status epilepticus (IV fosphenytoin); second-line for trigeminal neuralgia.

Carbamazepine

Iminostilbene anticonvulsant (sodium channel blocker)
1 ยท Mechanism
Use-dependent sodium channel blockade (like phenytoin), damping repetitive firing in seizure foci and trigeminal neurons.
2 ยท Adverse effect
SIADH hyponatraemia (especially elderly), agranulocytosis and aplastic anaemia, SJS in HLA-B*15:02 carriers, diplopia and ataxia, autoinduction of CYP3A4.
3 ยท Contraindications
History of bone marrow depression, AV block or heart failure, and concurrent MAOIs (wait 2 weeks); avoid in porphyria and with aromatic anticonvulsant allergy.
4 ยท Indication
Trigeminal neuralgia (drug of choice), focal and generalised tonic-clonic epilepsy, and acute mania.

Sodium Valproate

Broad-spectrum anticonvulsant (fatty acid)
1 ยท Mechanism
Blocks voltage-gated sodium channels while raising GABA by inhibiting its transaminase and boosting synthesis - a dual mechanism.
2 ยท Adverse effect
Idiosyncratic hepatotoxicity (highest risk under age 2), pancreatitis, hyperammonaemic encephalopathy, weight gain, tremor, hair loss, and severe teratogenicity (neural tube defects).
3 ยท Contraindications
Pregnancy or childbearing potential without effective contraception, urea cycle disorders, known mitochondrial POLG disease, and active liver disease.
4 ยท Indication
Generalised seizures including absence attacks, bipolar disorder and migraine prophylaxis.

Ethosuximide

Succinimide anticonvulsant
1 ยท Mechanism
Blocks T-type calcium channels in thalamic relay neurons, abolishing the 3 Hz spike-and-wave discharges of absence seizures.
2 ยท Adverse effect
Drowsiness, headache, nausea, hiccups, rash (rarely SJS) and rare blood dyscrasias.
3 ยท Contraindications
Hypersensitivity and caution in renal or hepatic impairment; not useful for tonic-clonic seizures (can worsen them).
4 ยท Indication
Absence seizures - the drug of choice, particularly in children.

Lamotrigine

Phenyltriazine anticonvulsant
1 ยท Mechanism
Blocks voltage-gated sodium channels, reducing presynaptic release of glutamate and other excitatory neurotransmitters.
2 ยท Adverse effect
Stevens-Johnson syndrome and toxic epidermal necrolysis if the dose escalates too fast, especially with valproate (levels double); also dizziness, diplopia and ataxia.
3 ยท Contraindications
Hypersensitivity, and valproate co-administration forces a 50 percent dose reduction; slow titration is mandatory after any interruption.
4 ยท Indication
Focal and generalised tonic-clonic epilepsy, and maintenance prophylaxis of bipolar depression.

Levetiracetam

Pyrrolidone anticonvulsant (SV2A ligand)
1 ยท Mechanism
Binds synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release - a mechanism shared by no other major antiepileptic.
2 ยท Adverse effect
Somnolence and fatigue, dizziness, and notable neuropsychiatric effects (irritability, aggression, rarely psychosis); no significant drug interactions.
3 ยท Contraindications
Hypersensitivity; dose reduction in renal impairment; caution with pre-existing behavioural or psychiatric disease.
4 ยท Indication
Broad-spectrum add-on therapy for focal and generalised seizures, and IV treatment of status epilepticus.

Phenobarbital

Long-acting barbiturate anticonvulsant
1 ยท Mechanism
Positive allosteric modulator at GABA-A receptors that lengthens chloride channel opening (barbiturate style), and at higher doses directly opens channels too.
2 ยท Adverse effect
Sedation and cognitive slowing, respiratory depression, strong hepatic enzyme induction (lowers warfarin and contraceptive levels), physical dependence and paradoxical hyperactivity in children.
3 ยท Contraindications
Hepatic porphyrias (absolutely), severe respiratory insufficiency and untreated alcohol or sedative withdrawal (withdrawal seizures).
4 ยท Indication
Neonatal seizures (widely first-line), low-cost generalised epilepsy, and second-line status epilepticus.

Diazepam

Long-acting benzodiazepine
1 ยท Mechanism
Enhances GABA-A receptor activity by increasing chloride channel opening frequency, producing anxiolysis, amnesia, muscle relaxation and sedation.
2 ยท Adverse effect
Sedation and anterograde amnesia, respiratory depression with opioids or alcohol, dependence and withdrawal seizures, paradoxical disinhibition in children and elderly, falls.
3 ยท Contraindications
Myasthenia gravis, severe respiratory failure or sleep apnoea, acute narrow-angle glaucoma and acute hepatic encephalopathy caution.
4 ยท Indication
First-line IV treatment of status epilepticus, anxiety, muscle spasm and spasticity, and alcohol withdrawal.

Zolpidem

Non-benzodiazepine Z-drug hypnotic
1 ยท Mechanism
Selective agonist at alpha-1 (BZD1, omega-1) GABA-A subunits, the subunit linked to sedation rather than anxiolysis.
2 ยท Adverse effect
Complex sleep behaviours (sleepwalking, sleep-driving - FDA boxed warning), next-day impairment and amnesia, dependence, and falls in the elderly.
3 ยท Contraindications
History of complex sleep behaviours, severe hepatic impairment, and concurrent alcohol or other CNS depressants.
4 ยท Indication
Short-term treatment of insomnia, particularly difficulty with sleep onset.

Buspirone

Azapironone anxiolytic (5-HT1A partial agonist)
1 ยท Mechanism
Partial agonist at presynaptic and postsynaptic 5-HT1A receptors, damping serotonergic tone - no GABA involvement at all.
2 ยท Adverse effect
Dizziness, headache, nausea and nervousness; notably no sedation, no dependence, no withdrawal and no interaction with alcohol; takes 2-4 weeks to work.
3 ยท Contraindications
Concurrent MAOIs (serotonin risk, 2-week washout) and strong CYP3A4 inhibitors such as grapefruit juice, which raise levels.
4 ยท Indication
Generalised anxiety disorder in patients who should not receive benzodiazepines.

Haloperidol

High-potency first-generation antipsychotic
1 ยท Mechanism
Strong D2 dopamine receptor blockade in mesolimbic pathways (with equally strong nigrostriatal blockade), plus mild alpha-1 and antihistamine effects.
2 ยท Adverse effect
Extrapyramidal effects (dystonia, akathisia, parkinsonism, tardive dyskinesia), neuroleptic malignant syndrome, hyperprolactinaemia, and QT prolongation with IV use.
3 ยท Contraindications
Comatose states, Parkinson's disease or depression (D2 blockade worsens them), known long-QT syndrome and severe hepatic impairment.
4 ยท Indication
Acute psychosis and agitated mania, chemotherapy-induced nausea (high-dose IV), and Huntington's chorea.

Chlorpromazine

Low-potency first-generation antipsychotic
1 ยท Mechanism
D2 antagonism layered with strong H1 antihistamine, antimuscarinic and alpha-1 blockade - the source of its sedation and hypotension.
2 ยท Adverse effect
Heavy sedation, orthostatic hypotension, photosensitivity, cholestatic jaundice, hyperprolactinaemia, and EPS (less than haloperidol).
3 ยท Contraindications
Coma and severe CNS depression, and absolutely no epinephrine (unopposed alpha action worsens shock); caution in epilepsy and hepatic disease.
4 ยท Indication
Psychosis and severe agitation, and the classic drug for intractable hiccups (singultus).

Clozapine

Atypical antipsychotic (dibenzodiazepine)
1 ยท Mechanism
Weak D2 blockade with strong 5-HT2A (plus D4, muscarinic and histamine) antagonism, giving efficacy where other antipsychotics fail.
2 ยท Adverse effect
Agranulocytosis (weekly blood monitoring mandatory), dose-related seizures, myocarditis, metabolic syndrome, sialorrhoea and constipation or ileus.
3 ยท Contraindications
Previous clozapine-induced agranulocytosis or severe neutropenia, and uncontrolled epilepsy; smoking cessation raises levels into toxicity.
4 ยท Indication
Treatment-resistant schizophrenia and reduction of suicidal behaviour in schizophrenia - no other drug matches it.

Risperidone

Atypical antipsychotic (benzisoxazole)
1 ยท Mechanism
Balanced D2 and 5-HT2A antagonism - enough serotonin blockade to offset extrapyramidal effects at low doses.
2 ยท Adverse effect
Hyperprolactinaemia (the highest of the atypicals - gynaecomastia, amenorrhoea), EPS at higher doses, orthostatic hypotension, weight gain.
3 ยท Contraindications
Parkinson's disease (D2 blockade) and caution in elderly dementia (increased mortality warning); dose-adjust in hepatic impairment.
4 ยท Indication
Schizophrenia, acute mania in bipolar disorder, and irritability in autism.

Imipramine

Tricyclic antidepressant (tertiary amine)
1 ยท Mechanism
Blocks noradrenaline and serotonin reuptake while adding anticholinergic, antihistaminic, alpha-1 and sodium channel effects.
2 ยท Adverse effect
Anticholinergic burden (dry mouth, constipation, urinary retention, blurred vision), sedation, orthostatic hypotension, weight gain, and cardiotoxic QRS widening in overdose.
3 ยท Contraindications
Recent myocardial infarction, arrhythmias or heart block, concurrent MAOIs (2-week gap), epilepsy and glaucoma or urinary retention caution.
4 ยท Indication
Childhood enuresis (classic first choice) and endogenous depression; related amines treat neuropathic pain.

Fluoxetine

Selective serotonin reuptake inhibitor (SSRI)
1 ยท Mechanism
Selective inhibition of the serotonin transporter (SERT), raising synaptic 5-HT; its norfluoxetine metabolite has an extremely long half-life.
2 ยท Adverse effect
Nausea and GI upset, headache, insomnia or activation, sexual dysfunction, hyponatraemia in the elderly, bleeding risk, and serotonin syndrome with other serotonergics.
3 ยท Contraindications
MAOIs (5-week washout because of the long-lived metabolite), and caution with linezolid, tramadol or triptans (serotonin risk).
4 ยท Indication
Depression, OCD (high dose) and bulimia nervosa - a first-line SSRI across several disorders.

Sertraline

Selective serotonin reuptake inhibitor (SSRI)
1 ยท Mechanism
Potent SERT inhibition with weak dopamine transporter activity; minimal inhibition of cytochrome P450 enzymes.
2 ยท Adverse effect
GI upset and diarrhoea (most common), headache, insomnia, sexual dysfunction, hyponatraemia, and discontinuation syndrome if stopped abruptly.
3 ยท Contraindications
Concurrent MAOIs (14-day washout both ways) and caution with other serotonergic agents.
4 ยท Indication
First-line for depression, panic disorder, PTSD, OCD, social anxiety and PMDD.

Venlafaxine

Serotonin-noradrenaline reuptake inhibitor (SNRI)
1 ยท Mechanism
Dose-dependent reuptake inhibition - serotonin at low doses, with noradrenaline recruited as the dose climbs; weak at D2 and histamine.
2 ยท Adverse effect
Dose-dependent hypertension at higher doses, nausea, sexual dysfunction, sweating, and a notoriously severe discontinuation syndrome (must taper).
3 ยท Contraindications
MAOIs, uncontrolled hypertension (monitor at high dose), and caution in narrow-angle glaucoma.
4 ยท Indication
Major depression after SSRI failure, generalised anxiety and panic disorder.

Amitriptyline

Tricyclic antidepressant (tertiary amine)
1 ยท Mechanism
Blocks serotonin and noradrenaline reuptake with heavy antihistamine and antimuscarinic sedation on top.
2 ยท Adverse effect
Marked sedation, anticholinergic effects, orthostatic hypotension, weight gain, and dangerous cardiotoxicity in overdose (sodium channel block).
3 ยท Contraindications
Recent myocardial infarction, arrhythmias or heart block, epilepsy, and MAOI co-administration.
4 ยท Indication
Migraine prophylaxis and neuropathic pain at low doses; depression at higher doses.

Selegiline

Selective irreversible MAO-B inhibitor
1 ยท Mechanism
Irreversibly inhibits monoamine oxidase B at low doses, sparing MAO-A and sparing dietary tyramine metabolism.
2 ยท Adverse effect
Insomnia, nausea, dizziness and dry mouth; above 10 mg/day selectivity is lost, allowing the cheese reaction; interactant serotonergic effects.
3 ยท Contraindications
Pethidine (meperidine) and SSRIs absolutely (serotonin syndrome), non-selective MAOIs, and tyramine-rich diets at higher doses.
4 ยท Indication
Early Parkinson's disease and adjunctive therapy with levodopa.

Levodopa

Dopamine precursor with peripheral decarboxylase inhibitor
1 ยท Mechanism
Crosses the blood-brain barrier and is decarboxylated to dopamine in the striatum; carbidopa blocks the same enzyme peripherally, cutting nausea and boosting delivery.
2 ยท Adverse effect
Long-term dyskinesias and on-off fluctuations, nausea and vomiting, postural hypotension, psychosis and hallucinations, pedal oedema.
3 ยท Contraindications
Narrow-angle glaucoma, non-selective MAOIs, high-dose vitamin B6 without carbidopa (destroys it peripherally), and uncontrolled psychiatric illness.
4 ยท Indication
Parkinson's disease - still the most effective symptomatic drug and the gold standard for motor control.

Amantadine

NMDA antagonist / antiviral (adamantane)
1 ยท Mechanism
Blocks NMDA glutamate receptors (relieving parkinsonian symptoms and dyskinesias) and was originally an influenza A M2 ion channel blocker.
2 ยท Adverse effect
Livedo reticularis, peripheral oedema, insomnia and nightmares, hallucinations in the elderly, and anticholinergic dry mouth.
3 ยท Contraindications
Uncontrolled epilepsy, severe renal impairment (dose reduced), and caution in heart failure or peripheral oedema.
4 ยท Indication
Parkinson's disease, especially levodopa-induced dyskinesias; historically influenza A prophylaxis.

Ropinirole

Non-ergot dopamine D2/D3 agonist
1 ยท Mechanism
Direct stimulation of postsynaptic D2 and D3 receptors in the striatum, substituting for dopamine without needing decarboxylation.
2 ยท Adverse effect
Nausea (dose-limiting), sudden sleep attacks with a driving risk, hallucinations, orthostatic hypotension, and impulse-control disorders (pathological gambling, compulsive shopping).
3 ยท Contraindications
Psychosis or severe psychiatric illness (caution), and co-administration with antihypertensives (additive hypotension).
4 ยท Indication
Early Parkinson's disease as a levodopa-sparing agent, and restless legs syndrome.

Donepezil

Central acetylcholinesterase inhibitor
1 ยท Mechanism
Reversibly inhibits acetylcholinesterase in the cortex and hippocampus, raising acetylcholine in cholinergic circuits lost in Alzheimer's disease.
2 ยท Adverse effect
Diarrhoea and nausea (cholinergic), bradycardia and AV block with syncope, insomnia, muscle cramps and vivid dreams.
3 ยท Contraindications
Sick sinus syndrome or symptomatic bradycardia (may need a pacemaker first), and caution in asthma, COPD and bladder outflow obstruction.
4 ยท Indication
Symptomatic treatment of mild to moderate Alzheimer's disease.

Memantine

Low-affinity NMDA receptor antagonist
1 ยท Mechanism
Voltage-dependent, low-affinity blockade of NMDA receptors that dampens glutamate excitotoxicity without blocking normal synaptic transmission.
2 ยท Adverse effect
Dizziness, headache, confusion, constipation, and dose-related hallucinations.
3 ยท Contraindications
Severe renal impairment (dose reduction) and caution with other NMDA-active drugs (amantadine, ketamine); usual caution in seizure risk.
4 ยท Indication
Moderate to severe Alzheimer's disease, frequently combined with donepezil.

Sumatriptan

Triptan (5-HT1B/1D agonist)
1 ยท Mechanism
Agonist at 5-HT1B receptors on cranial arteries (vasoconstriction) and 5-HT1D on trigeminal terminals (blocks CGRP release), shutting down migraine physiology.
2 ยท Adverse effect
Chest tightness or pressure (triptan sensations), tingling, dizziness, coronary vasospasm, serotonin syndrome risk with SSRIs, and medication-overuse headache beyond 10 days a month.
3 ยท Contraindications
Ischaemic heart disease, uncontrolled hypertension, prior stroke or TIA, haemiplegic or basilar migraine, and MAOI use within 2 weeks.
4 ยท Indication
Acute relief of a migraine attack (not prophylaxis) - taken at onset.

Methylphenidate

CNS stimulant (catecholamine reuptake inhibitor)
1 ยท Mechanism
Blocks the dopamine and noradrenaline transporters, raising catecholamines in the prefrontal cortex to improve attention and inhibition.
2 ยท Adverse effect
Appetite suppression and weight loss, insomnia, tachycardia and raised blood pressure, growth delay in children, abuse liability (Schedule II) and psychosis at high doses.
3 ยท Contraindications
MAOIs (14-day gap), glaucoma or hyperthyroidism caution, known structural cardiac abnormalities or sudden-death risk, and active agitation or psychosis.
4 ยท Indication
Attention deficit hyperactivity disorder (first-line stimulant) and narcolepsy.

Lithium

Mood stabiliser (alkali metal salt)
1 ยท Mechanism
Multifaceted and still not fully pinned down - inhibits inositol monophosphatase and GSK-3, damping inositol second-messenger signalling and neuronal excitability; mood effects take days to weeks.
2 ยท Adverse effect
Narrow therapeutic index: coarse tremor, polyuria and polydipsia (nephrogenic diabetes insipidus), hypothyroidism, weight gain, teratogenicity (Ebstein anomaly), and toxicity with vomiting, ataxia and confusion.
3 ยท Contraindications
Severe renal or cardiovascular disease, sodium depletion or dehydration, and NSAIDs, thiazides or ACE inhibitors (all raise lithium levels); pregnancy requires risk-benefit discussion.
4 ยท Indication
Bipolar disorder - acute mania and long-term prophylaxis; the classic mood stabiliser with a proven reduction in suicide risk.

Cardiovascular 21

Digoxin

Cardiac glycoside (Na+/K+-ATPase inhibitor)
1 ยท Mechanism
Inhibits myocardial Na+/K+-ATPase, raising intracellular sodium so the Na+/Ca2+ exchanger loads calcium - more contractility; vagal action slows AV conduction.
2 ยท Adverse effect
Narrow therapeutic index: nausea, anorexia, yellow-green visual halos, confusion and arrhythmias - classically provoked by hypokalaemia (K+ and digoxin compete for the same pump).
3 ยท Contraindications
Ventricular fibrillation, complete heart block and hypertrophic obstructive cardiomyopathy; correct hypokalaemia first and beware amiodarone or verapamil interactions.
4 ยท Indication
Rate control in atrial fibrillation and symptomatic systolic heart failure - a narrow-index drug where toxicity is a classic presenting problem.

Amiodarone

Class III antiarrhythmic (potassium channel blocker)
1 ยท Mechanism
Mainly blocks potassium channels, prolonging repolarisation and refractoriness, layered with sodium channel, calcium channel and mild beta-blocking actions.
2 ยท Adverse effect
Pulmonary fibrosis, thyroid dysfunction (it is about one-third iodine - hypo or hyper), hepatotoxicity, corneal microdeposits, blue-grey skin, photosensitivity and QT prolongation.
3 ยท Contraindications
Severe sinus bradycardia or SA block, uncorrected thyroid disease, and caution with other QT-prolonging drugs; avoided in pregnancy.
4 ยท Indication
Rhythm control in atrial fibrillation and life-threatening ventricular arrhythmias - effective but with the heaviest monitoring burden of any antiarrhythmic.

Adenosine

Endogenous purine nucleoside (ultra-short-acting)
1 ยท Mechanism
Activates A1 receptors in the AV node, opening potassium channels and hyperpolarising the node - transient conduction block with a half-life under 10 seconds.
2 ยท Adverse effect
Transient chest tightness and flushing, a sense of impending doom, brief high-grade AV block or asystole, and bronchoconstriction.
3 ยท Contraindications
Asthma or COPD (bronchospasm), second- or third-degree AV block without a pacemaker, and sick sinus syndrome; dipyridamole potentiates it.
4 ยท Indication
First-line acute termination of re-entrant supraventricular tachycardia - rapid IV bolus with the arm raised to flush it centrally.

Verapamil

Non-dihydropyridine calcium channel blocker (phenylalkylamine)
1 ยท Mechanism
Blocks L-type calcium channels preferentially in the heart - slows AV nodal conduction and contractility while still dilating arteries.
2 ยท Adverse effect
Constipation (most common and dose-limiting), bradycardia and AV block, hypotension and peripheral oedema - notably no reflex tachycardia.
3 ยท Contraindications
Sick sinus syndrome or second/third-degree AV block, severe heart failure with reduced ejection fraction, and concurrent beta-blockers or ivabradine (additive depression).
4 ยท Indication
Rate control in atrial fibrillation, prophylaxis of SVT, hypertension and angina - unlike dihydropyridines, it is avoided in heart failure.

Propranolol

Non-selective beta-adrenergic blocker
1 ยท Mechanism
Blocks beta-1 and beta-2 receptors: falls in heart rate, contractility and renin release, plus central beta-2 action dampening tremor.
2 ยท Adverse effect
Bradycardia and AV block, bronchoconstriction (and it masks the tachycardia warning of hypoglycaemia), cold extremities, fatigue, vivid dreams and rebound tachycardia on abrupt withdrawal.
3 ยท Contraindications
Bronchial asthma or severe COPD (absolute), decompensated heart failure, high-degree AV block, and cocaine-associated or MAOI hypertension (unopposed alpha effects).
4 ยท Indication
Hypertension, migraine prophylaxis, essential tremor, thyrotoxicosis symptoms and rate control in atrial fibrillation.

Captopril

ACE inhibitor (sulfhydryl-containing)
1 ยท Mechanism
Inhibits angiotensin-converting enzyme, blocking angiotensin II formation while also preventing bradykinin breakdown - vasodilation with less afterload and aldosterone.
2 ยท Adverse effect
Dry cough (bradykinin-mediated, the classic reason to switch to an ARB), hyperkalaemia, first-dose hypotension, angioedema, and taste disturbance from the sulfhydryl group.
3 ยท Contraindications
Pregnancy, bilateral renal artery stenosis, prior angioedema with any ACE inhibitor, hyperkalaemia, and additive renal risk with NSAIDs.
4 ยท Indication
Hypertension (especially with proteinuria), heart failure, post-myocardial infarction and diabetic nephropathy - renoprotective.

Losartan

Angiotensin II receptor blocker (AT1 antagonist)
1 ยท Mechanism
Competitively blocks AT1 receptors so angiotensin II cannot vasoconstrict, release aldosterone or remodel the heart - bradykinin is untouched, hence no cough.
2 ยท Adverse effect
Dizziness, hyperkalaemia, renal impairment when volume-depleted; unlike ACE inhibitors it causes almost no cough, but it is still teratogenic later in pregnancy.
3 ยท Contraindications
Pregnancy, bilateral renal artery stenosis, hyperkalaemia, and dual RAAS blockade with an ACE inhibitor or aliskiren in diabetes.
4 ยท Indication
Hypertension, diabetic nephropathy and heart failure - favoured in hypertensive patients with gout because it is uricosuric.

Amlodipine

Dihydropyridine calcium channel blocker
1 ยท Mechanism
L-type calcium channel blockade concentrated on vascular smooth muscle, relaxing arterioles with minimal direct cardiac depression.
2 ยท Adverse effect
Dose-dependent ankle oedema (arteriolar dilation, not fluid overload, so diuretics do not fix it), flushing, headache, dizziness and gum hyperplasia.
3 ยท Contraindications
Severe hypotension, cardiogenic shock (absolute), and caution in decompensated heart failure or severe aortic stenosis.
4 ยท Indication
Hypertension and chronic stable angina - among the most prescribed antihypertensives worldwide.

Hydrochlorothiazide

Thiazide diuretic
1 ยท Mechanism
Inhibits the Na+/Cl- cotransporter in the distal convoluted tubule; chronic use also lowers peripheral vascular resistance.
2 ยท Adverse effect
Hypokalaemia, hyponatraemia (notably in elderly women), hyperuricaemia precipitating gout, hyperglycaemia, hypercalcaemia, photosensitivity rash and dyslipidaemia.
3 ยท Contraindications
Anuria, severe renal impairment (ineffective at low GFR), gout (relative), pregnancy, and prior sulfonamide allergy is a caution.
4 ยท Indication
First-line hypertension (often paired with a potassium-sparing drug) - and it lowers urinary calcium, so it also prevents calcium stones.

Furosemide

Loop diuretic
1 ยท Mechanism
Blocks the Na+/K+/2Cl- cotransporter in the thick ascending limb - the most powerful diuretic class, collapsing the medullary concentration gradient.
2 ยท Adverse effect
Hypokalaemia, hypomagnesaemia, hypocalcaemia, dehydration, hyperuricaemia (gout), and ototoxicity especially with rapid IV push or aminoglycosides.
3 ยท Contraindications
Severe volume depletion or anuria, and caution with digoxin - hypokalaemia potentiates digoxin toxicity directly.
4 ยท Indication
Acute pulmonary oedema (IV), decompensated heart failure, ascites and severe oedema - the go-to when rapid diuresis is needed.

Spironolactone

Potassium-sparing aldosterone antagonist
1 ยท Mechanism
Competitive antagonist of aldosterone at mineralocorticoid receptors in the collecting duct - retains sodium and water, excretes potassium, with cardiac anti-fibrotic effects.
2 ยท Adverse effect
Hyperkalaemia (the dangerous one), gynaecomastia and breast tenderness via sex-hormone effects, menstrual irregularity, and acute renal failure if overdiuresed.
3 ยท Contraindications
Hyperkalaemia, significant renal impairment, Addison disease, and concurrent potassium supplements or other potassium-sparing drugs; pregnancy (antiandrogen effects).
4 ยท Indication
Heart failure with reduced ejection fraction (mortality benefit), resistant hypertension, cirrhotic ascites and primary hyperaldosteronism.

Methyldopa

Centrally acting alpha-2 agonist (prodrug)
1 ยท Mechanism
Converted to methyl-noradrenaline, stimulating central alpha-2 receptors to dampen sympathetic outflow from the brainstem and reduce renin release.
2 ยท Adverse effect
Sedation and dry mouth, a positive Coombs test with haemolytic anaemia in up to a fifth of patients, hepatitis, oedema, and rebound hypertension on withdrawal.
3 ยท Contraindications
Active hepatic disease (drug-induced hepatitis risk), concurrent MAOIs, and phaeochromocytoma (it may provoke hypertensive crisis).
4 ยท Indication
Hypertension in pregnancy - the classic preferred central agent during gestation.

Hydralazine

Direct-acting arteriolar vasodilator
1 ยท Mechanism
Relaxes arteriolar smooth muscle by an uncertain mechanism involving inositol phosphate signalling and nitric oxide release - pure afterload reduction.
2 ยท Adverse effect
Reflex tachycardia, headache, flushing, fluid retention, and a drug-induced lupus-like syndrome with chronic high doses (ANA positive).
3 ยท Contraindications
Systemic lupus erythematosus, severe tachyarrhythmias, and caution in coronary disease because reflex tachycardia can provoke ischaemia.
4 ยท Indication
Severe hypertension in pregnancy (with methyldopa) and heart failure - usually combined with a beta-blocker to blunt reflex tachycardia.

Nitroglycerin

Organic nitrate (venodilator)
1 ยท Mechanism
Releases nitric oxide, activating guanylyl cyclase and raising cGMP - venous dilation cuts preload while coronary dilation relieves spasm.
2 ยท Adverse effect
Throbbing headache (most common), flushing, dizziness, hypotension, reflex tachycardia, and tolerance with continuous use (needs a nitrate-free interval).
3 ยท Contraindications
Phosphodiesterase-5 inhibitors such as sildenafil within 24-48 hours (severe hypotension), severe aortic stenosis, hypotension, and raised intracranial pressure.
4 ยท Indication
Acute angina attack (sublingual) and acute pulmonary oedema; patches or ointment for prophylaxis.

Atorvastatin

HMG-CoA reductase inhibitor (statin)
1 ยท Mechanism
Competitively inhibits HMG-CoA reductase, the rate-limiting cholesterol enzyme, upregulating LDL receptors so plasma LDL is cleared faster.
2 ยท Adverse effect
Myalgia and myopathy, rare rhabdomyolysis (risk climbs with CYP3A4 inhibitors), raised transaminases, new-onset diabetes risk and headache.
3 ยท Contraindications
Pregnancy and breastfeeding (generally stopped), active liver disease, and strong CYP3A4 inhibitors such as clarithromycin, itraconazole or grapefruit juice.
4 ยท Indication
Hypercholesterolaemia and cardiovascular risk reduction - LDL lowering with proven event reduction.

Warfarin

Vitamin K epoxide reductase antagonist (coumarin)
1 ยท Mechanism
Inhibits vitamin K epoxide reductase, blocking recycling of vitamin K so clotting factors II, VII, IX and X cannot be gamma-carboxylated.
2 ยท Adverse effect
Bleeding (main risk), early skin necrosis in protein C deficiency, purple toe syndrome, hair loss, and huge variability from food (vitamin K greens) and drug interactions.
3 ยท Contraindications
Pregnancy (absolutely - teratogenic in the first trimester and causes fetal haemorrhage later), active bleeding and severe hepatic disease.
4 ยท Indication
Atrial fibrillation stroke prevention, venous thromboembolism, and mechanical heart valves - monitored by INR (reversed by vitamin K or PCC).

Heparin

Antithrombin III activator (glycosaminoglycan)
1 ยท Mechanism
Binds antithrombin III and accelerates its neutralisation of thrombin and factor Xa roughly thousandfold - anticoagulation with immediate IV effect.
2 ยท Adverse effect
Bleeding, heparin-induced thrombocytopenia (immune type II - paradoxical clots), osteoporosis on long-term use, alopecia and hypersensitivity.
3 ยท Contraindications
Active bleeding, previous HIT, severe thrombocytopenia, and caution with lumbar puncture or intramuscular injection (haematoma risk).
4 ยท Indication
Immediate anticoagulation in DVT and pulmonary embolism (bridging to warfarin), in pregnancy (does not cross the placenta), and during dialysis.

Clopidogrel

Thienopyridine antiplatelet (P2Y12 blocker)
1 ยท Mechanism
A prodrug irreversibly blocking the ADP P2Y12 receptor, preventing GPIIb/IIIa activation so platelets cannot aggregate for their whole lifespan.
2 ยท Adverse effect
Bleeding, thrombotic thrombocytopenic purpura (rare), dyspepsia and rash - and CYP2C19 poor metabolisers get no active drug at all.
3 ยท Contraindications
Active bleeding, severe hepatic impairment, and avoid with omeprazole (CYP2C19 inhibition blocks its activation - pantoprazole is the swap); pregnancy caution.
4 ยท Indication
Acute coronary syndromes and post-stent dual antiplatelet therapy, plus secondary prevention after stroke.

Alteplase

Thrombolytic (fibrin-specific plasminogen activator)
1 ยท Mechanism
Converts plasminogen to plasmin on the fibrin surface, digesting the clot - reperfusion therapy given IV within a strict time window.
2 ยท Adverse effect
Haemorrhage including the feared intracranial haemorrhage, allergic reactions, reperfusion arrhythmias and systemic fibrinogen depletion.
3 ยท Contraindications
Active internal bleeding, any intracranial neoplasm or arteriovenous malformation, intracranial or intraspinal surgery within 2 months, and suspected aortic dissection.
4 ยท Indication
Acute ischaemic stroke within 4.5 hours, ST-elevation myocardial infarction, and massive pulmonary embolism - time-critical reperfusion.

Sodium nitroprusside

Direct IV vasodilator (nitric oxide donor)
1 ยท Mechanism
Releases nitric oxide, relaxing arteriolar AND venous smooth muscle at once - instant preload and afterload reduction, titrated drop by drop.
2 ยท Adverse effect
Cyanide toxicity (confusion, lactic acidosis) and thiocyanate accumulation with prolonged infusion, precipitous hypotension, reflex tachycardia and raised intracranial pressure.
3 ยท Contraindications
Compensatory hypertension states such as aortic stenosis, raised intracranial pressure, and caution in renal or hepatic failure - limit infusion to about 48-72 hours with monitoring.
4 ยท Indication
Hypertensive emergencies and controlled hypotension during surgery - the classic titratable IV vasodilator when minute-by-minute control is needed.

Metoprolol

Cardioselective beta-1 adrenergic blocker
1 ยท Mechanism
Selectively blocks cardiac beta-1 receptors, slowing heart rate and contractility and suppressing renin release - cardioselectivity fades as the dose climbs.
2 ยท Adverse effect
Bradycardia and AV block, fatigue and cold extremities, bronchospasm at higher doses, masked hypoglycaemia symptoms, and erectile dysfunction.
3 ยท Contraindications
Decompensated heart failure, high-degree AV block and severe bradycardia; caution in asthma (cardioselectivity is relative) and never stop abruptly - rebound ischaemia follows.
4 ยท Indication
Hypertension, angina, secondary prevention after myocardial infarction, heart failure with reduced ejection fraction (succinate) and rate control in atrial fibrillation.

Respiratory 8

Salbutamol

Short-acting selective beta-2 agonist (SABA)
1 ยท Mechanism
Selective beta-2 stimulation raises cAMP in bronchial smooth muscle, relaxing it within minutes - the archetypal rescue inhaler.
2 ยท Adverse effect
Tremor, tachycardia and palpitations, hypokalaemia (beta-2 drives potassium intracellularly), headache, and tolerance to tachycardia with overuse.
3 ยท Contraindications
No absolute asthma contraindication, but caution in thyrotoxicosis, arrhythmias and concurrent QT-prolonging drugs; nebule overdoses in children cause hypokalaemia.
4 ยท Indication
First-line reliever for acute asthma and COPD bronchospasm (and pre-exercise prophylaxis).

Salmeterol

Long-acting beta-2 agonist (LABA)
1 ยท Mechanism
Highly lipophilic beta-2 agonist that anchors beside the receptor, giving about 12 hours of bronchodilation with little peak effect.
2 ยท Adverse effect
Tremor and tachycardia, and a small increased risk of asthma-related death when used as monotherapy in asthma (the salmeterol controversy).
3 ยท Contraindications
Never as monotherapy in asthma - it must be paired with an inhaled corticosteroid, and it is too slow to be a rescue inhaler.
4 ยท Indication
Maintenance treatment of asthma (always with an ICS) and COPD - the I in the SMART/ICS-LABA concept.

Theophylline

Methylxanthine bronchodilator
1 ยท Mechanism
Phosphodiesterase inhibition raising cAMP plus adenosine receptor antagonism - relaxes bronchial smooth muscle and mildly stimulates respiration.
2 ยท Adverse effect
Very narrow therapeutic index: nausea and vomiting first, then tachycardia, arrhythmias, seizures and death - toxicity is triggered by infection, fever, erythromycin or ciprofloxacin.
3 ยท Contraindications
Uncontrolled arrhythmias, active peptic ulcer, epilepsy and severe cardiac or hepatic disease; levels must be monitored because interactions are frequent.
4 ยท Indication
Stable asthma or COPD uncontrolled on inhaled therapy - now seldom used because safer inhalers exist.

Montelukast

Leukotriene receptor antagonist (CysLT1)
1 ยท Mechanism
Blocks cysteinyl leukotriene receptors, preventing LTD4-driven bronchoconstriction, mucus secretion and eosinophilic inflammation.
2 ยท Adverse effect
Headache and upper respiratory symptoms, vivid dreams, and a boxed warning for serious neuropsychiatric events (agitation, depression, suicidality).
3 ยท Contraindications
Not for acute bronchospasm (far too slow), caution with neuropsychiatric history, and abrupt steroid withdrawal can unmask eosinophilic vasculitis.
4 ยท Indication
Add-on asthma control, prophylaxis of exercise-induced bronchoconstriction, and allergic rhinitis.

Ipratropium

Short-acting inhaled antimuscarinic
1 ยท Mechanism
Quaternary atropine analogue blocking M3 receptors on airway smooth muscle, preventing vagal bronchoconstriction; poorly absorbed so minimal systemic anticholinergic effects.
2 ยท Adverse effect
Dry mouth, blurred vision if the mist reaches the eye (mydriasis), constipation rarely, urinary retention in susceptible men, and paradoxical bronchospasm.
3 ยท Contraindications
Narrow-angle glaucoma (keep nebuliser mist away from the eyes) and bladder outflow obstruction (caution); peanut allergy applied to some older formulations.
4 ยท Indication
COPD (paired with a SABA as the standard dual rescue) and as adjunct in acute severe asthma.

Budesonide

Inhaled corticosteroid (ICS)
1 ยท Mechanism
Activates glucocorticoid receptors in airway epithelium to repress NF-kB-driven cytokines - cutting eosinophilic inflammation and oedema over weeks.
2 ยท Adverse effect
Oropharyngeal candidiasis (thrush - rinse and spit or use a spacer), dysphonia, reduced growth velocity in children at high doses, bruising, adrenal suppression at very high doses.
3 ยท Contraindications
Active untreated pulmonary tuberculosis or fungal airway infection (treat first) - otherwise it is the foundation of asthma therapy.
4 ยท Indication
First-line controller for persistent asthma (ICS are what prevent asthma deaths) and maintenance in COPD.

Omalizumab

Anti-IgE monoclonal antibody
1 ยท Mechanism
Binds free IgE at the site where IgE would attach Fc epsilon RI, lowering circulating IgE and downregulating mast cell and basophil receptors.
2 ยท Adverse effect
Injection-site reactions, headache, and anaphylaxis (observation for 30-90 minutes after early injections is required).
3 ยท Contraindications
Previous anaphylaxis to omalizumab or its excipients; watch for eosinophilia and vasculitis if oral steroids are being withdrawn.
4 ยท Indication
Severe allergic asthma uncontrolled on inhaled steroids with raised IgE, and chronic spontaneous urticaria.

Acetylcysteine

Mucolytic and paracetamol antidote
1 ยท Mechanism
Its free thiol breaks disulfide bonds in mucus to liquefy it, and it replenishes hepatic glutathione so NAPQI is detoxified in paracetamol poisoning.
2 ยท Adverse effect
Nausea, vomiting and diarrhoea (rate-related on the IV protocol), bronchospasm in asthmatics, and rare anaphylactoid reactions with IV infusion.
3 ยท Contraindications
Caution in active asthma (aerosolised form can bronchospasm), and dose adjustment in severe renal impairment.
4 ยท Indication
The definitive antidote to paracetamol overdose (IV or oral NAC) and a mucolytic for thick bronchial secretions.

Endocrine & Reproductive 16

Insulin

Anabolic peptide hormone (rapid to long-acting analogues)
1 ยท Mechanism
Binding its receptor tyrosine kinase drives GLUT4 translocation and glycogen, protein and lipid synthesis while switching off gluconeogenesis.
2 ยท Adverse effect
Hypoglycaemia (the main danger - tremor, sweating, confusion, seizures, coma), lipodystrophy at injection sites, weight gain, hypokalaemia and allergy.
3 ยท Contraindications
Never omitted in type 1 diabetes (ketoacidosis follows); caution with skipped meals, hepatic or renal impairment - there is no safe dose without food on board.
4 ยท Indication
Type 1 diabetes (obligatory), diabetic ketoacidosis, hyperkalaemia (with glucose), and type 2 diabetes when oral agents fail.

Metformin

Biguanide antidiabetic
1 ยท Mechanism
Activates AMP-activated protein kinase, suppressing hepatic gluconeogenesis and improving insulin sensitivity - it does not force insulin release, so it rarely causes hypoglycaemia alone.
2 ยท Adverse effect
Diarrhoea, nausea and metallic taste (worst at the start), vitamin B12 deficiency on long-term use, and rare lactic acidosis (risk climbs with renal failure and hypoxia).
3 ยท Contraindications
Severe renal impairment (eGFR below 30), metabolic acidosis, hypoxic states (heart failure, sepsis, liver disease), heavy alcohol use, and hold 48 hours around iodinated contrast.
4 ยท Indication
First-line for type 2 diabetes - UKPDS showed reduced cardiovascular mortality in overweight patients, and it rarely causes hypoglycaemia alone.

Glibenclamide

Second-generation sulfonylurea
1 ยท Mechanism
Closes ATP-sensitive potassium channels on beta cells, forcing depolarisation, calcium influx and insulin release irrespective of glucose level.
2 ยท Adverse effect
Prolonged hypoglycaemia (especially in the elderly and renal failure), weight gain, rash, and dangerous persistent hyperinsulinism in overdose.
3 ยท Contraindications
Type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and sulfa allergy is a caution; avoided in pregnancy (neonatal hypoglycaemia).
4 ยท Indication
Type 2 diabetes when metformin alone is insufficient - cheap and effective but hypoglycaemia-prone.

Pioglitazone

Thiazolidinedione (PPAR-gamma agonist)
1 ยท Mechanism
Activates PPAR-gamma in adipose and muscle, reprogramming gene expression to improve insulin sensitivity and move fat out of liver and muscle.
2 ยท Adverse effect
Weight gain and fluid retention (worsens heart failure), oedema, increased fracture risk in women, lipodystrophy, and a possible bladder cancer signal.
3 ยท Contraindications
Heart failure NYHA class II-IV (FDA warning), active bladder cancer, and severe hepatic impairment.
4 ยท Indication
Insulin resistance in type 2 diabetes, especially with non-alcoholic fatty liver disease - it improves steatosis.

Sitagliptin

DPP-4 inhibitor (gliptin)
1 ยท Mechanism
Inhibits dipeptidyl peptidase-4, prolonging endogenous GLP-1 and GIP so insulin rises only when glucose is high (incretin effect restored).
2 ยท Adverse effect
Nasopharyngitis, headache and upper respiratory symptoms; rare pancreatitis signal; no hypoglycaemia and weight-neutral as monotherapy.
3 ยท Contraindications
Type 1 diabetes or diabetic ketoacidosis (ineffective), severe renal impairment (dose adjustment), and prior pancreatitis is a caution.
4 ยท Indication
Type 2 diabetes add-on to metformin - weight-neutral with low hypoglycaemia risk.

Empagliflozin

SGLT2 inhibitor (gliflozin)
1 ยท Mechanism
Blocks sodium-glucose cotransporter 2 in the proximal tubule, wasting 70-80 grams of glucose daily in the urine (glycosuria).
2 ยท Adverse effect
Genital mycotic infections and urinary tract infections from glycosuria, euglycaemic diabetic ketoacidosis (acidosis with near-normal glucose), volume depletion, rare Fournier gangrene.
3 ยท Contraindications
Type 1 diabetes (ketoacidosis risk), severe renal impairment (no glycosuric effect), recurrent genital infections, and fasting or ketogenic diets.
4 ยท Indication
Type 2 diabetes with proven cardiovascular and heart failure benefit - also slows chronic kidney disease progression.

Liraglutide

GLP-1 receptor agonist (incretin mimetic)
1 ยท Mechanism
Long-acting GLP-1 analogue that amplifies glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying and reduces appetite centrally.
2 ยท Adverse effect
Nausea and vomiting (dose-limiting), diarrhoea, pancreatitis signal, gallstones from rapid weight loss, injection-site reactions, and rodent thyroid C-cell tumours.
3 ยท Contraindications
Personal or family history of medullary thyroid carcinoma or MEN2 (boxed warning), prior pancreatitis (caution), and gastroparesis.
4 ยท Indication
Type 2 diabetes and chronic weight management, with proven cardiovascular outcome benefit.

Levothyroxine

Synthetic thyroid hormone (T4)
1 ยท Mechanism
Deiodinated to active T3, binding nuclear thyroid receptors to raise basal metabolic rate, thermogenesis and cardiac output.
2 ยท Adverse effect
Over-replacement mimics hyperthyroidism - tachycardia, tremor, insomnia, weight loss, atrial fibrillation and osteoporosis in postmenopausal women.
3 ยท Contraindications
Uncorrected adrenal insufficiency (replacement can precipitate adrenal crisis - glucocorticoids first) and acute myocardial infarction.
4 ยท Indication
Hypothyroidism of all causes, myxoedema coma (IV), and TSH suppression after thyroid cancer.

Propylthiouracil

Thioamide antithyroid drug
1 ยท Mechanism
Inhibits thyroid peroxidase, blocking iodine organification and coupling - and uniquely it also blocks peripheral conversion of T4 to T3.
2 ยท Adverse effect
Agranulocytosis (sore throat means stop and count cells), hepatotoxicity (hepatocellular, worse than methimazole especially in children), rash, arthralgia, drug fever.
3 ยท Contraindications
Prior thioamide-induced agranulocytosis or hepatitis; in the first trimester methimazole is preferred (PTU is the later-pregnancy choice).
4 ยท Indication
Graves hyperthyroidism - particularly first-trimester pregnancy and thyroid storm, because it blocks T4 to T3 conversion.

Hydrocortisone

Natural corticosteroid (glucocorticoid + mineralocorticoid)
1 ยท Mechanism
Binds glucocorticoid receptors to repress NF-kB inflammatory genes, while retaining meaningful mineralocorticoid (aldosterone-like) activity.
2 ยท Adverse effect
Weight gain, moon facies, hyperglycaemia, hypertension, osteoporosis, adrenal suppression with chronic dosing, infection reactivation and poor wound healing.
3 ยท Contraindications
Systemic fungal infections (relative), live vaccines at immunosuppressive doses - but uncorrected adrenal insufficiency must always be replaced, never withheld.
4 ยท Indication
Adrenal crisis (IV - the lifesaving replacement dose), adrenal insufficiency, and broad anti-inflammatory or immunosuppressive use.

Prednisolone

Intermediate-acting synthetic glucocorticoid
1 ยท Mechanism
Potent NF-kB trans-repression plus membrane stabilisation, shutting down cytokine and prostaglandin synthesis with far more potency than hydrocortisone.
2 ยท Adverse effect
Cushingoid change, hyperglycaemia, adrenal suppression (taper needed after about 3 weeks of use), osteoporosis, cataract, growth suppression in children.
3 ยท Contraindications
Systemic fungal infection, live vaccines at immunosuppressive doses, and caution with diabetes, hypertension, osteoporosis and psychiatric history.
4 ยท Indication
Chronic inflammatory and autoimmune disease - asthma exacerbations, rheumatoid arthritis, nephrotic syndrome, IBD and transplant rejection.

Dexamethasone

Potent long-acting synthetic glucocorticoid
1 ยท Mechanism
Very high glucocorticoid potency with almost no mineralocorticoid activity, and long receptor residence allowing once-daily dosing.
2 ยท Adverse effect
Cushingoid effects, adrenal suppression, insomnia and euphoria, hyperglycaemia, immunosuppression, and ocular herpes risk (corneal melting).
3 ยท Contraindications
Systemic fungal infection, live vaccines, and caution in diabetes, psychosis history and ocular herpes simplex.
4 ยท Indication
Croup in children (single dose), fetal lung maturation between 24-34 weeks, cerebral oedema, and chemotherapy antiemesis.

Octreotide

Long-acting somatostatin analogue
1 ยท Mechanism
Mimics somatostatin at all five receptor subtypes, suppressing GH, insulin, glucagon and gut peptides while constricting splanchnic vessels.
2 ยท Adverse effect
Injection-site pain, nausea, gallstones (it slows gallbladder motility), dysglycaemia, steatorrhoea and vitamin B12 malabsorption on long-term use.
3 ยท Contraindications
Hypersensitivity (older long-acting formulations contained peanut oil - classic exam point), and caution in gallstones and diabetes.
4 ยท Indication
Carcinoid tumour flushing and diarrhoea, acromegaly when surgery fails, and oesophageal variceal bleeding.

Oxytocin

Posterior pituitary peptide hormone
1 ยท Mechanism
Stimulates oxytocin receptors on myometrium via Gq, raising intracellular calcium for coordinated uterine contraction, and triggers milk ejection.
2 ยท Adverse effect
Uterine tetany and hyperstimulation with fetal distress, water intoxication and hyponatraemia from rapid IV infusion, postpartum haemorrhage if misused.
3 ยท Contraindications
Active genital infection, previous classical caesarean section or uterine rupture, cephalopelvic disproportion and fetal malpresentation - never induced without excluding these.
4 ยท Indication
Induction and augmentation of labour, and control of postpartum haemorrhage (the standard uterotonic).

Desmopressin

Synthetic vasopressin (V2) analogue
1 ยท Mechanism
Selective V2 agonist in the collecting duct, inserting aquaporin-2 channels for water reabsorption with minimal V1 pressor activity.
2 ยท Adverse effect
Water retention and dilutional hyponatraemia (the main danger, especially in children and the elderly), headache, facial flushing, nasal irritation.
3 ยท Contraindications
History of hyponatraemia, uncontrolled hypertension or heart failure (fluid overload), and compulsive polydipsia - monitor sodium.
4 ยท Indication
Central diabetes insipidus, nocturnal enuresis, and mild haemophilia A or von Willebrand disease (it releases vWF and factor VIII).

Tamoxifen

Selective estrogen receptor modulator (SERM)
1 ยท Mechanism
Competitive estrogen receptor antagonist in breast tissue but a partial agonist in bone and uterus - blocks estrogen-driven tumour growth.
2 ยท Adverse effect
Hot flushes, vaginal dryness and discharge, endometrial hyperplasia and cancer (uterine agonism), thromboembolic events and mood effects.
3 ยท Contraindications
Prior venous thromboembolism (caution), pregnancy and breastfeeding - and CYP2D6 inhibitors like fluoxetine block its activation to endoxifen.
4 ยท Indication
Adjuvant treatment of estrogen-receptor-positive breast cancer for 5-10 years, and risk reduction in high-risk women.

Gastrointestinal 11

Omeprazole

Proton pump inhibitor (benzimidazole)
1 ยท Mechanism
Irreversibly inhibits the H+/K+-ATPase on parietal cell canaliculi - the final step of acid secretion - so new pumps must be synthesised before acid returns.
2 ยท Adverse effect
Increased C. difficile and enteric infection risk, hypomagnesaemia and low B12 on long-term use, rebound acid secretion on withdrawal, bone fracture risk, headache.
3 ยท Contraindications
Atazanavir or rilpivirine (they need stomach acid), and avoid with clopidogrel - omeprazole inhibits CYP2C19, so switch to pantoprazole.
4 ยท Indication
GERD, peptic ulcer disease, H. pylori regimens, Zollinger-Ellison syndrome (high dose) and NSAID ulcer prophylaxis.

Ranitidine

Histamine H2 receptor antagonist (withdrawn)
1 ยท Mechanism
Competitively blocks H2 receptors on parietal cells, reducing basal and food-stimulated acid - weaker than a pump inhibitor.
2 ยท Adverse effect
Headache, constipation or diarrhoea, confusion in the elderly or renal failure - and the brand was withdrawn worldwide for NDMA contamination.
3 ยท Contraindications
Withdrawn from most markets since 2020 for probable carcinogenic NDMA impurities - replaced by famotidine or PPIs; hypersensitivity otherwise.
4 ยท Indication
Historically GERD and ulcers - now the classic exam answer about NDMA-related drug withdrawals rather than a live treatment choice.

Magnesium & Aluminum Hydroxide

Non-systemic acid-neutralising antacid
1 ยท Mechanism
Chemically neutralise gastric HCl, raising pH within minutes - magnesium salts cause diarrhoea while aluminium salts cause constipation (hence rational combinations).
2 ยท Adverse effect
Diarrhoea (magnesium) or constipation (aluminium), hypermagnesaemia in renal failure, phosphate depletion with chronic aluminium, and reduced absorption of other drugs by chelation.
3 ยท Contraindications
Severe renal impairment (magnesium accumulation), chronic aluminium use in renal failure, and bowel obstruction (constipating component).
4 ยท Indication
Dyspepsia and heartburn relief - also binds aspirin, iron and tetracyclines, so doses are separated by two hours.

Ondansetron

5-HT3 receptor antagonist (setron)
1 ยท Mechanism
Blocks serotonin type-3 receptors on vagal afferents in the gut and in the chemoreceptor trigger zone, cutting the emetic reflex.
2 ยท Adverse effect
Headache and constipation (most common), QT prolongation especially with rapid IV push, mild LFT rise, and serotonin syndrome risk with tramadol.
3 ยท Contraindications
Known long-QT syndrome or concurrent QT-prolonging drugs, congenital long QT, and caution with other serotonergics.
4 ยท Indication
Chemotherapy- and radiotherapy-induced vomiting, postoperative nausea, and a single dose for acute gastroenteritis (widely used in children).

Metoclopramide

D2 antagonist prokinetic (benzamide)
1 ยท Mechanism
Blocks D2 receptors in the chemoreceptor trigger zone while enhancing acetylcholine release in the gut, speeding gastric emptying upward and forward.
2 ยท Adverse effect
Drowsiness, restlessness, and with repeated doses acute dystonia and tardive dyskinesia (potentially irreversible), plus galactorrhoea from hyperprolactinaemia.
3 ยท Contraindications
Gastrointestinal obstruction, epilepsy (lowers threshold), and avoid in children for routine gastroenteritis (tardive dyskinesia risk); caution with antipsychotics.
4 ยท Indication
Chemotherapy-induced nausea (with a setron), gastroparesis and diabetic dyspepsia, and migraine-associated nausea.

Domperidone

Peripheral D2 antagonist (prokinetic)
1 ยท Mechanism
Blocks D2 receptors in the area postrema and gut wall without crossing the blood-brain barrier, so it avoids central extrapyramidal effects.
2 ยท Adverse effect
QT prolongation and torsades (EMA imposed dose and duration limits), galactorrhoea and amenorrhoea, dry mouth, headache.
3 ยท Contraindications
Known long-QT syndrome, concurrent QT-prolonging drugs, hepatic impairment, and strong CYP3A4 inhibitors such as ketoconazole or erythromycin.
4 ยท Indication
Nausea and vomiting and gastroparesis - chosen when metoclopramide's extrapyramidal effects must be avoided.

Loperamide

Peripheral mu-opioid agonist (antidiarrhoeal)
1 ยท Mechanism
Acts on mu receptors in the myenteric plexus, slowing peristalsis and increasing fluid absorption; it does not cross the BBB at therapeutic doses.
2 ยท Adverse effect
Constipation, cramps, nausea - and deliberate mega-dosing causes fatal cardiac arrhythmias (QT prolongation and torsades).
3 ยท Contraindications
Acute dysentery or invasive bacterial diarrhoea (fever or blood in stool - antimotility traps toxin), active ulcerative colitis, caution in hepatic failure.
4 ยท Indication
Acute non-specific diarrhoea and traveller's diarrhoea - and it is the template for opioid-induced constipation as an adverse effect.

Misoprostol

Prostaglandin E1 analogue
1 ยท Mechanism
Binds EP receptors on parietal cells to inhibit acid secretion and boosts protective mucus and bicarbonate in the mucosa.
2 ยท Adverse effect
Diarrhoea and abdominal cramping (most common), uterine contraction causing abortion or fetal harm, fever and shivering.
3 ยท Contraindications
Pregnancy (absolute - it is an abortifacient), prostaglandin hypersensitivity, and caution with uterine dysfunction or seizure disorders.
4 ยท Indication
Prevention of NSAID-induced gastric ulcers in high-risk patients, plus obstetric uses (cervical ripening, postpartum haemorrhage).

Sucralfate

Mucosal protectant (sucrose sulfate-aluminium complex)
1 ยท Mechanism
In acid it polymerises and sticks to exposed ulcer protein, forming a paste resistant to acid, pepsin and bile, while stimulating prostaglandin and bicarbonate.
2 ยท Adverse effect
Constipation, dry mouth, aluminium absorption in renal failure, and binding interactions with other drugs (space doses by two hours).
3 ยท Contraindications
Renal impairment (aluminium accumulation), GI obstruction, and concurrent antacids or PPIs (it needs pH below 4 to polymerise).
4 ยท Indication
Duodenal ulcer and stress ulcer prophylaxis in the ICU.

Bismuth Subsalicylate

Bismuth-salicylate mucosal protectant
1 ยท Mechanism
Coats the gastric mucosa, has mild antimicrobial action, binds C. difficile toxin, and adds antisecretory effect via local prostaglandin action.
2 ยท Adverse effect
Harmless black stools and black tongue from bismuth, tinnitus and salicylate toxicity at high doses, and constipation.
3 ยท Contraindications
Aspirin allergy, active or recent GI bleeding (salicylate), and caution in renal impairment or with anticoagulants.
4 ยท Indication
Traveller's diarrhoea and dyspepsia - plus a component of H. pylori quadruple therapy.

Lactulose

Synthetic disaccharide osmotic laxative
1 ยท Mechanism
Unabsorbed sugar that draws water osmotically; colonic bacteria cleave it to acids that trap ammonia as ammonium while the osmotic load causes catharsis.
2 ยท Adverse effect
Bloating, flatulence, cramps and dose-limiting diarrhoea, plus electrolyte disturbance if overused.
3 ยท Contraindications
Galactosaemia and galactose or fructose intolerance (it contains both), and GI obstruction.
4 ยท Indication
Constipation in the elderly and hepatic encephalopathy - where diarrhoea is precisely the therapeutic goal.

Antibacterials & Anti-TB 21

Penicillin G

Beta-lactam antibiotic (narrow spectrum, parenteral)
1 ยท Mechanism
Binds penicillin-binding proteins (transpeptidases), preventing peptidoglycan cross-linking so the growing cell wall ruptures (bactericidal).
2 ยท Adverse effect
Hypersensitivity up to anaphylaxis, Jarisch-Herxheimer reaction in spirochete infections, and convulsions after rapid high-dose IV, especially in renal failure.
3 ยท Contraindications
Previous penicillin anaphylaxis (cephalosporin cross-reactivity is low but depends on side-chain similarity), and dose reduction in renal failure.
4 ยท Indication
Streptococcal and meningococcal infections, syphilis (drug of choice) and actinomycosis.

Amoxicillin

Aminopenicillin (oral beta-lactam)
1 ยท Mechanism
Same penicillin-binding protein target as penicillin G, with an amino group adding Gram-negative penetration and acid stability for oral dosing.
2 ยท Adverse effect
Diarrhoea and a non-allergic maculopapular rash (common in children given ampicillin during EBV), hypersensitivity, and candida overgrowth.
3 ยท Contraindications
Prior penicillin or ampicillin hypersensitivity - and the ampicillin rash during EBV or CMV is not a true allergy label.
4 ยท Indication
Otitis media, respiratory tract infections, H. pylori regimens and dental prophylaxis - the workhorse oral penicillin.

Cloxacillin

Penicillinase-resistant penicillin (anti-staphylococcal)
1 ยท Mechanism
A bulky side chain sterically shields the beta-lactam ring from staphylococcal penicillinase, so it still reaches its PBPs despite the enzyme.
2 ยท Adverse effect
Rash, hypersensitivity, hepatitis with prolonged high-dose therapy, and neutropenia.
3 ยท Contraindications
Penicillin hypersensitivity - and it fails against MRSA, whose altered PBP2a (mecA) does not bind it.
4 ยท Indication
Penicillinase-producing staphylococcal skin and soft tissue infections - never used for MRSA.

Ceftriaxone

Third-generation cephalosporin
1 ยท Mechanism
High-affinity binding to Gram-negative PBPs with beta-lactamase stability, giving broad Gram-negative coverage and excellent CSF penetration.
2 ยท Adverse effect
Biliary pseudolithiasis (sludge in children - classic), hypersensitivity (caution after penicillin anaphylaxis), C. difficile diarrhoea, and neutropenia.
3 ยท Contraindications
Newborns receiving calcium-containing IV solutions (ceftriaxone-calcium precipitates), and any history of immediate penicillin anaphylaxis is a caution.
4 ยท Indication
Community-acquired pneumonia, gonorrhoea, Lyme disease and meningitis cover - the broadest-spectrum cephalosporin.

Vancomycin

Glycopeptide antibiotic
1 ยท Mechanism
Binds the D-Ala-D-Ala terminus of peptidoglycan precursors, physically blocking cross-linking; only works on dividing organisms.
2 ยท Adverse effect
Red man syndrome from rapid infusion (histamine flushing - not a true allergy), nephrotoxicity, ototoxicity, and thrombophlebitis at high local concentration.
3 ยท Contraindications
Combination with other nephrotoxins or ototoxins (aminoglycosides, loop diuretics), and IV vancomycin does not treat CNS infection; slow infusion prevents flushing.
4 ยท Indication
Serious MRSA infections, and oral vancomycin for Clostridioides difficile colitis (drug of choice - poorly absorbed, so it stays in the gut).

Erythromycin

First-generation macrolide antibiotic
1 ยท Mechanism
Binds the 50S ribosomal subunit at 23S rRNA, blocking translocation - bacteriostatic, becoming cidal at high concentrations.
2 ยท Adverse effect
GI upset from motilin-receptor prokinetic action (its most common side effect), cholestatic hepatitis, QT prolongation, and strong CYP3A4 inhibition with many interactions.
3 ยท Contraindications
Concurrent terfenadine, astemizole, pimozide or ergot alkaloids (CYP3A4 interactions causing torsades or ergotism), and caution with other QT-prolonging drugs.
4 ยท Indication
Penicillin-allergic respiratory infections, atypical pneumonia, Legionella and Mycoplasma - plus a prokinetic for gastroparesis.

Azithromycin

Azalide macrolide antibiotic
1 ยท Mechanism
Binds the 50S subunit like erythromycin but with very high tissue penetration and a long half-life - once-daily dosing and short courses.
2 ยท Adverse effect
QT prolongation (especially with other QT drugs), mild GI upset, rare ototoxicity and hepatotoxicity - and far fewer CYP interactions than erythromycin.
3 ยท Contraindications
Macrolide allergy and caution with other QT-prolonging drugs.
4 ยท Indication
Atypical pneumonia, chlamydia, otitis media and the famous three-day course for community-acquired pneumonia.

Clindamycin

Lincosamide antibiotic
1 ยท Mechanism
Binds the 50S ribosomal subunit and blocks translocation of the peptidyl-tRNA - bacteriostatic, cidal against some staphylococci.
2 ยท Adverse effect
Pseudomembranous colitis from C. difficile toxin (can begin after therapy stops - its signature toxicity), rash, raised liver enzymes, neuromuscular blockade in myasthenia.
3 ยท Contraindications
Previous antibiotic-associated colitis (relative) and caution in myasthenia gravis; do not combine its oral anaerobe cover with metronidazole.
4 ยท Indication
Severe anaerobic and staphylococcal infections - dental abscess, aspiration pneumonia, toxic shock and penicillin allergy.

Gentamicin

Aminoglycoside antibiotic
1 ยท Mechanism
Binds the 30S ribosomal subunit, causing misreading of mRNA - concentration-dependent, uptake-dependent bactericidal killing.
2 ยท Adverse effect
Irreversible ototoxicity (hearing loss and vertigo) and nephrotoxicity (acute tubular necrosis), plus neuromuscular blockade at high doses - redose by serum levels.
3 ยท Contraindications
Other nephro- or ototoxic drugs (vancomycin, loop diuretics), myasthenia gravis, and renal impairment (therapeutic drug monitoring mandatory).
4 ยท Indication
Synergy with beta-lactams for severe Gram-negative sepsis and endocarditis, and empirical therapy in febrile neutropenia.

Tetracycline

Tetracycline antibiotic (bacteriostatic)
1 ยท Mechanism
Binds the 30S subunit at the A site, blocking aminoacyl-tRNA entry and so halting protein synthesis.
2 ยท Adverse effect
Calcium binding causes tooth discoloration and enamel hypoplasia in children, bone growth retardation, photosensitivity, pill oesophagitis and GI upset.
3 ยท Contraindications
Children under 8 years and pregnancy (tooth and bone effects); dairy, antacids and iron chelate it, so doses are separated - renal failure uses doxycycline instead.
4 ยท Indication
Rickettsial infections (typhus, Rocky Mountain spotted fever), cholera, brucellosis and chlamydia - the intracellular pathogen specialist.

Chloramphenicol

Amphenicol antibiotic (bacteriostatic)
1 ยท Mechanism
Binds the 50S subunit and blocks peptidyl transferase, stopping protein synthesis - broad activity undermined by toxicity.
2 ยท Adverse effect
Dose-related reversible bone marrow suppression, idiosyncratic aplastic anaemia (fatal and irreversible), and grey baby syndrome in neonates (immature glucuronidation).
3 ยท Contraindications
Pregnancy, neonates and infants (grey baby syndrome), and other marrow-suppressing drugs - blood counts are required during therapy.
4 ยท Indication
Typhoid fever (oral), bacterial meningitis in resource-limited settings (excellent CSF penetration) and rickettsial infections.

Linezolid

Oxazolidinone antibiotic
1 ยท Mechanism
Binds 23S rRNA of the 50S subunit at a unique site, blocking formation of the 70S initiation complex - no cross-resistance with any other class.
2 ยท Adverse effect
Myelosuppression (thrombocytopenia - counts after 2 weeks), irreversible peripheral or optic neuropathy with prolonged use, serotonin syndrome, lactic acidosis.
3 ยท Contraindications
Treatment beyond 28 days without monitoring, concurrent serotonergic drugs (it is a weak MAO inhibitor), and uncontrolled hypertension (caution).
4 ยท Indication
MRSA and vancomycin-resistant enterococci when glycopeptides fail - the last-line oral Gram-positive agent.

Colistin

Polymyxin antibiotic (cationic detergent)
1 ยท Mechanism
Displaces divalent cations from the Gram-negative outer membrane, disrupting it like a cationic detergent - external action, hence toxicity.
2 ยท Adverse effect
Nephrotoxicity (dose-limiting rising creatinine) and neurotoxicity (paresthesia, ataxia, respiratory paralysis with high levels).
3 ยท Contraindications
Neuromuscular disorders (respiratory depression risk) and renal impairment (dose by renal function); avoid stacking with other nephrotoxins.
4 ยท Indication
Multidrug-resistant Gram-negative infections, especially carbapenem-resistant Acinetobacter - the last-resort polymyxin.

Cotrimoxazole

Sulfonamide + DHFR inhibitor (sequential folate blockade)
1 ยท Mechanism
Sulfamethoxazole blocks dihydropteroate synthase and trimethoprim blocks dihydrofolate reductase - two sequential steps in the same folate pathway.
2 ยท Adverse effect
Rash and Stevens-Johnson syndrome (higher risk in HIV), megaloblastic anaemia, hyperkalaemia (trimethoprim acts like a potassium-sparing drug), photosensitivity, cytopenias.
3 ยท Contraindications
Severe sulfonamide allergy, pregnancy (folate antagonism, especially near term), G6PD deficiency (haemolysis), and renal impairment combined with ACE inhibitors or spironolactone.
4 ยท Indication
Pneumocystis jirovecii pneumonia prophylaxis and treatment in HIV, UTI, and MRSA skin infection.

Metronidazole

Nitroimidazole antibiotic and antiprotozoal
1 ยท Mechanism
Reduced by anaerobes and protozoa to cytotoxic free radicals that shred DNA - selectively lethal in low-oxygen cells.
2 ยท Adverse effect
Metallic taste, nausea, disulfiram-like reaction with alcohol (flushing, vomiting), peripheral neuropathy on prolonged use, dark urine.
3 ยท Contraindications
Alcohol during and for 48 hours after therapy (disulfiram reaction), first trimester of pregnancy, and neurological disease (seizure threshold) caution.
4 ยท Indication
Anaerobic infections (Bacteroides, aspiration pneumonia), trichomoniasis, giardiasis and amoebic liver abscess.

Dapsone

Sulfone (folate synthesis inhibitor)
1 ยท Mechanism
Inhibits dihydropteroate synthase like sulfonamides, blocking folate synthesis - and it is also anti-inflammatory in dermatitis herpetiformis.
2 ยท Adverse effect
Methaemoglobinaemia (cyanosis - treated with methylene blue), haemolytic anaemia (especially with G6PD deficiency), peripheral neuropathy, and the dapsone reaction in leprosy.
3 ยท Contraindications
G6PD deficiency (test first - severe haemolysis), severe anaemia, and prior dapsone hypersensitivity.
4 ยท Indication
Leprosy (with rifampicin and clofazimine in WHO multidrug therapy) and dermatitis herpetiformis.

Isoniazid

First-line antitubercular (prodrug)
1 ยท Mechanism
A prodrug activated by catalase-peroxidase (KatG); its reactive metabolite inactivates InhA, blocking mycolic acid synthesis for the mycobacterial wall.
2 ยท Adverse effect
Hepatotoxicity (the dose-limiting, age-related toxicity), peripheral neuropathy from pyridoxine depletion (prevent with vitamin B6), rash, lupus-like syndrome.
3 ยท Contraindications
Active liver disease (relative) and caution with alcohol or prior isoniazid hepatitis - vitamin B6 is given routinely to prevent neuropathy.
4 ยท Indication
All forms of tuberculosis - the anchor drug given for six months in essentially every regimen.

Rifampicin

First-line antitubercular (ansamycin)
1 ยท Mechanism
Binds the beta subunit of bacterial DNA-dependent RNA polymerase, blocking transcription - rapidly bactericidal and sterilising.
2 ยท Adverse effect
Orange-red urine, tears and contact lenses, hepatitis, flu-like syndrome with intermittent dosing, thrombocytopenia, and powerful hepatic enzyme induction.
3 ยท Contraindications
Active viral hepatitis - and it induces CYP3A4 so oral contraceptives, warfarin, methadone and protease inhibitors all lose effect (barrier contraception advised).
4 ยท Indication
Tuberculosis (all regimens), leprosy, staphylococcal prosthetic infections and Legionella.

Pyrazinamide

First-line antitubercular (nicotinamide derivative)
1 ยท Mechanism
Activated by pyrazinamidase to pyrazinoic acid, which disrupts membrane potential in acidic, hypoxic niches - it kills dormant bacilli.
2 ยท Adverse effect
Hepatotoxicity (a major contributor to regimen toxicity), hyperuricaemia that can precipitate gout, arthralgia, rash and nausea.
3 ยท Contraindications
Severe hepatic disease, gout (relative - monitor uric acid), and caution with diabetes (may worsen control).
4 ยท Indication
The intensive phase of TB treatment (first two months of 2RHZE then 4RH) - it sterilises caseous centres and shortens therapy.

Ethambutol

First-line antitubercular (ethylenediamine)
1 ยท Mechanism
Inhibits arabinosyl transferases, blocking arabinogalactan synthesis and so cross-linking of the mycobacterial cell wall.
2 ยท Adverse effect
Optic neuritis - lost red-green colour discrimination and falling visual acuity (dose-related, worse in renal impairment), plus hyperuricaemia.
3 ยท Contraindications
Pre-existing visual impairment or optic neuritis (baseline eye test needed) and dose reduction in renal failure.
4 ยท Indication
Added to TB regimens for resistance coverage - with monthly visual acuity and colour vision checks during therapy.

Ciprofloxacin

Fluoroquinolone antibiotic (DNA gyrase inhibitor)
1 ยท Mechanism
Inhibits bacterial DNA gyrase and topoisomerase IV, unwinding and cutting DNA so replication cannot proceed - concentration-dependent killing of Gram-negatives.
2 ยท Adverse effect
Tendinopathy and Achilles tendon rupture, QT prolongation, peripheral neuropathy and CNS effects, aortic aneurysm risk, and C. difficile colitis.
3 ยท Contraindications
Prior quinolone tendon rupture, myasthenia gravis, and caution with other QT-prolonging drugs; avoid routine use in children and pregnancy (cartilage effects) outside anthrax post-exposure.
4 ยท Indication
Gram-negative infections - urinary tract infections, typhoid fever, anthrax post-exposure prophylaxis and travellers diarrhoea - respiratory cover varies by local resistance.

Antifungal, Antiviral, Antimalarial & Antihelminthic 15

Fluconazole

Triazole antifungal
1 ยท Mechanism
Inhibits fungal CYP51 (lanosterol 14-alpha demethylase), depleting ergosterol so the fungal membrane falls apart.
2 ยท Adverse effect
Nausea, headache, alopecia, hepatitis, QT prolongation - and CYP2C9/2C19 inhibition raises warfarin and phenytoin levels.
3 ยท Contraindications
Concurrent terfenadine, astemizole or cisapride (contraindicated - torsades), and caution in hepatic disease and on warfarin, phenytoin or sulfonylureas.
4 ยท Indication
Oropharyngeal and oesophageal candidiasis, cryptococcal meningitis maintenance and vaginal candidiasis - the most used systemic azole.

Amphotericin B

Polyene antifungal (IV)
1 ยท Mechanism
Binds ergosterol, forming pores in the fungal membrane so contents leak - but it also binds cholesterol, which is why it is so toxic.
2 ยท Adverse effect
Infusion reactions with rigors and fever (premedicate), nephrotoxicity and hypokalaemia (dose-limiting), anaemia, and red infusion colour ('amphoterrible').
3 ยท Contraindications
Severe renal impairment (liposomal formulation used instead), and caution with other nephrotoxins; historically a test dose was given.
4 ยท Indication
Life-threatening systemic mycoses: cryptococcal meningitis, mucormycosis and salvage therapy for aspergillosis.

Nystatin

Polyene antifungal (topical/oral, non-absorbed)
1 ยท Mechanism
Binds ergosterol and creates pores in fungal membranes - its size prevents absorption, so it only works where it sits in the gut lumen or on skin.
2 ยท Adverse effect
Local irritation, nausea from the sweet vehicle and unpleasant taste - essentially no systemic toxicity because none is absorbed.
3 ยท Contraindications
Hypersensitivity only - it cannot touch invasive fungal infection because it never reaches the bloodstream.
4 ยท Indication
Oral thrush (swish and swallow) and cutaneous or intestinal candidiasis.

Voriconazole

Second-generation triazole antifungal
1 ยท Mechanism
Inhibits CYP51 with broader coverage than fluconazole, including Aspergillus and fluconazole-resistant Candida.
2 ยท Adverse effect
Visual disturbance (blurred vision - very common early), marked photosensitivity with squamous cell carcinoma risk (sun protection is mandatory), rash, hepatitis, hallucinations.
3 ยท Contraindications
Concurrent terfenadine, astemizole, carbamazepine, rifampin or sirolimus (CYP interactions), hepatic impairment, and inherited retinitis pigmentosa.
4 ยท Indication
Invasive aspergillosis (drug of choice) and fluconazole-resistant or invasive candidiasis.

Caspofungin

Echinocandin antifungal
1 ยท Mechanism
Inhibits beta-1,3-glucan synthase, destroying a cell wall polysaccharide humans do not have - hence low host toxicity.
2 ยท Adverse effect
Histamine-like infusion reactions (flushing, phlebitis), fever, headache and raised liver enzymes; levels rise with cyclosporine.
3 ยท Contraindications
Hypersensitivity to any echinocandin; caution with cyclosporine and tacrolimus (levels rise); minimal CYP interactions.
4 ยท Indication
Invasive candidiasis and candidaemia (IV first line), plus salvage therapy for aspergillosis.

Acyclovir

Nucleoside analogue antiviral (guanosine)
1 ยท Mechanism
Phosphorylated first by viral thymidine kinase then by host kinases to a triphosphate that chains-terminates viral DNA polymerase - activation only in infected cells.
2 ยท Adverse effect
IV crystalline nephropathy (especially with dehydration - infuse, do not bolus), phlebitis, neurotoxicity (tremor, confusion) in renal impairment, rash.
3 ยท Contraindications
Dehydration and renal impairment (dose by eGFR); it is useless against acyclovir-resistant HSV (foscarnet is next).
4 ยท Indication
Herpes simplex (oral, genital, encephalitis) and varicella-zoster (shingles) - the archetype DNA virus drug.

Oseltamivir

Neuraminidase inhibitor (prodrug)
1 ยท Mechanism
Carboxylated in the liver to its active acid, which blocks influenza neuraminidase so new virions cannot detach from the infected cell.
2 ยท Adverse effect
Nausea and vomiting (take with food), headache, insomnia, and rare neuropsychiatric events reported particularly in Japanese paediatric data.
3 ยท Contraindications
Essentially hypersensitivity only - but dose adjustment is needed in renal failure, and it only shortens illness if started within 48 hours of onset.
4 ยท Indication
Treatment and prophylaxis of influenza A and B, most valuable when started early in high-risk patients.

Tenofovir

Nucleotide reverse transcriptase inhibitor (NtRTI)
1 ยท Mechanism
Incorporated as tenofovir diphosphate, it chain-terminates proviral DNA synthesis by HIV reverse transcriptase and HBV polymerase.
2 ยท Adverse effect
Proximal renal tubular dysfunction (Fanconi syndrome) and reduced bone density (less with the alafenamide prodrug), rare lactic acidosis.
3 ยท Contraindications
Pre-existing renal impairment (dose limits or switch agent) and prior tenofovir nephrotoxicity; stack carefully with NSAIDs or aminoglycosides.
4 ยท Indication
Cornerstone of HIV regimens and first-line for chronic hepatitis B (stopping it can cause dangerous flare).

Chloroquine

4-aminoquinoline antimalarial (and anti-inflammatory)
1 ยท Mechanism
Accumulates in the parasite's acidic food vacuole and blocks heme polymerisation, so toxic free heme accumulates and poisons the parasite.
2 ยท Adverse effect
Retinopathy with chronic high-dose use (annual eye screening), intense pruritus (notably in African patients), nausea, myopathy, cardiotoxicity in overdose.
3 ยท Contraindications
Retinal or macular disease, and caution with QT-prolonging drugs; it may also aggravate psoriasis.
4 ยท Indication
Malaria prophylaxis and treatment in chloroquine-sensitive regions, plus rheumatoid arthritis or lupus (anti-inflammatory use).

Artemether

Artemisinin derivative (fast-acting antimalarial)
1 ยท Mechanism
Its endoperoxide bridge releases free radicals that alkylate heme and parasite proteins, killing blood-stage Plasmodium within hours.
2 ยท Adverse effect
Nausea and vomiting, QT prolongation (from the lumefantrine partner), rare hepatotoxicity, and delayed haemolysis after IV artesunate in severe malaria.
3 ยท Contraindications
First trimester of pregnancy in many labels (though WHO now permits use when benefits outweigh risks), and concurrent QT-prolonging drugs.
4 ยท Indication
Uncomplicated falciparum malaria - artemisinin-based combination therapy is the WHO first-line worldwide.

Primaquine

8-aminoquinoline (radical cure)
1 ยท Mechanism
Oxidative metabolites kill hypnozoites in the liver and gametocytes - the classic radical cure that clears the dormant relapsing reservoir of P. vivax and P. ovale (tafenoquine is the newer single-dose option).
2 ยท Adverse effect
Acute haemolysis in G6PD deficiency (anaemia, jaundice, dark urine), methaemoglobinaemia with cyanosis, nausea.
3 ยท Contraindications
G6PD deficiency (test first - absolutely contraindicated), pregnancy, and breastfeeding unless infant GPD status is checked.
4 ยท Indication
Radical cure to prevent relapse of P. vivax and P. ovale, plus blocking transmission via gametocytes.

Albendazole

Benzimidazole anthelmintic
1 ยท Mechanism
Binds beta-tubulin and paralyses the worm's microtubule machinery, shutting down glucose uptake - the parasite starves.
2 ยท Adverse effect
Abdominal pain, nausea, headache, transient LFT rise; raised intracranial pressure when treating neurocysticercosis (give steroids), marrow suppression with prolonged high doses.
3 ยท Contraindications
Pregnancy (teratogenic - contraception during and one month after), pre-existing liver disease (caution), and ocular cysticercosis needs steroid cover first.
4 ยท Indication
Neurocysticercosis (with steroids), hydatid disease and broad intestinal nematode infection.

Praziquantel

Isoquinoline anthelmintic (antischistosomal)
1 ยท Mechanism
Opens tegument calcium channels, paralysing the worm with spastic contraction and exposing its surface antigens to host immunity.
2 ยท Adverse effect
Dizziness, drowsiness, nausea and abdominal pain, and transient worsening in neurocysticercosis (cerebral oedema - needs steroid cover).
3 ยท Contraindications
Ocular cysticercosis (inflammation destroys the eye - treat eyes first), and caution in children under four and severe hepatic disease.
4 ยท Indication
Schistosomiasis of all species (drug of choice) and cestode infections such as tapeworm and neurocysticercosis.

Ivermectin

Avermectin anthelmintic
1 ยท Mechanism
Potentiates glutamate-gated chloride channels (and GABA in invertebrates), paralysing the worm's pharynx and body wall - channels absent in humans at these doses.
2 ยท Adverse effect
Mazzotti-like reaction in onchocerciasis (itching, fever, hypotension as microfilariae die), headache, dizziness, and rare severe encephalopathy in heavy Loa loa co-infection.
3 ยท Contraindications
Concurrent Loa loa hyperparasitaemia (fatal encephalopathy risk), pregnancy, and children under 15 kg.
4 ยท Indication
Onchocerciasis - river blindness (drug of choice) - plus strongyloidiasis and mass drug administration programmes.

Diethylcarbamazine

Piperazine anthelmintic (antifilarial)
1 ยท Mechanism
Alters the microfilarial surface so the host immune system recognises it, and it also inhibits arachidonic acid release in the worm.
2 ยท Adverse effect
Mazzotti-type reaction (fever, myalgia, hypotension from dying microfilariae), headache, nausea and dizziness.
3 ยท Contraindications
Onchocerciasis (contraindicated - massive microfilarial load makes the Mazzotti reaction dangerous) and pregnancy.
4 ยท Indication
Lymphatic filariasis elimination (with albendazole in mass programmes).

Chemotherapy, Immunomodulators & Misc 15

Methotrexate

Folate antagonist (antimetabolite, DMARD)
1 ยท Mechanism
Inhibits dihydrofolate reductase (and at high dose thymidylate synthase), starving cells of reduced folates needed for thymine and purine synthesis.
2 ยท Adverse effect
Marrow suppression and mucositis, chronic low-dose hepatotoxicity with fibrosis, pneumonitis, high-dose nephrotoxicity (alkalinise and hydrate), teratogenicity.
3 ยท Contraindications
Pregnancy (absolute), significant renal or hepatic impairment, pre-existing cytopenias and alcohol-related liver disease - leucovorin rescue at high dose.
4 ยท Indication
Leukaemia and lymphoma (high dose with leucovorin rescue), rheumatoid arthritis (low dose), psoriasis and ectopic pregnancy.

Cyclophosphamide

Alkylating agent (nitrogen mustard prodrug)
1 ยท Mechanism
Cytochrome P450 converts it to phosphoramide mustard, which cross-links DNA strands - with acrolein shed as a toxic byproduct.
2 ยท Adverse effect
Haemorrhagic cystitis from acrolein (prevented by mesna and hydration), myelosuppression, SIADH, alopecia, gonadal failure and secondary malignancies.
3 ยท Contraindications
Severe bone marrow suppression, active infection, pregnancy (teratogenic), and live vaccines while immunosuppressed.
4 ยท Indication
Inducing remission in nephrotic syndrome, lymphomas, leukaemias and lupus nephritis - the workhorse alkylator.

Fluorouracil

Pyrimidine analogue (antimetabolite)
1 ยท Mechanism
As FdUMP it irreversibly inhibits thymidylate synthase while its metabolites also jam into RNA - both routes block DNA synthesis.
2 ยท Adverse effect
Severe mucositis, diarrhoea, hand-foot syndrome (palmar-plantar erythrodysesthesia), myelosuppression and, with bolus regimens, cardiotoxicity.
3 ยท Contraindications
Dihydropyrimidine dehydrogenase (DPD) deficiency - life-threatening toxicity, pregnancy, and severe bone marrow suppression.
4 ยท Indication
Colorectal cancer (with leucovorin), head and neck and breast cancers - with capecitabine as its oral prodrug.

Doxorubicin

Anthracycline antibiotic (topoisomerase II poison)
1 ยท Mechanism
Intercalates DNA and poisons topoisomerase II while generating free radicals - powerfully effective and powerfully cardiotoxic.
2 ยท Adverse effect
Cumulative dose-dependent dilated cardiomyopathy (lifetime ceiling around 450-550 mg/m2), acute arrhythmias, alopecia, myelosuppression, red urine (harmless), extravasation ulceration.
3 ยท Contraindications
Pre-existing cardiomyopathy (baseline echo required), prior maximum cumulative anthracycline dose, and additive risk with trastuzumab.
4 ยท Indication
Breast cancer, lymphomas, leukaemias and sarcomas - one of the most important anticancer drugs ever developed.

Cisplatin

Platinum agent (DNA cross-linker)
1 ยท Mechanism
Forms platinum-DNA intra- and interstrand cross-links that block replication and transcription - cell-cycle nonspecific.
2 ยท Adverse effect
Profound nephrotoxicity (mandatory pre- and post-hydration), dose-limiting ototoxicity (high-frequency hearing loss), severe emesis, neuropathy, hypomagnesaemia.
3 ยท Contraindications
Pre-existing renal impairment or significant hearing loss, pregnancy (teratogenic), and prior severe platinum hypersensitivity (carboplatin is the substitute).
4 ยท Indication
Testicular, ovarian, bladder, head and neck and lung cancers - the backbone of curative germ cell therapy.

Vincristine

Vinca alkaloid (microtubule inhibitor)
1 ยท Mechanism
Binds tubulin and prevents microtubule assembly, arresting mitosis in metaphase - disruption of axonal transport causes its neurotoxicity.
2 ยท Adverse effect
Dose-limiting peripheral neuropathy (paraesthesia, foot drop, ileus and constipation), jaw pain, alopecia - and fatal if given intrathecally.
3 ยท Contraindications
Biliary obstruction (biliary excretion - dose reduce), pre-existing neuropathy - and absolute: never intrathecal (fatal neurotoxicity, never IV push into a poor line).
4 ยท Indication
Acute lymphoblastic leukaemia, lymphomas and paediatric solid tumours - the cornerstone of childhood cancer regimens.

Paclitaxel

Taxane (microtubule stabiliser)
1 ยท Mechanism
Stabilises microtubules and prevents their depolymerisation, freezing the mitotic spindle so cells cannot complete division.
2 ยท Adverse effect
Hypersensitivity to the Cremophor vehicle (premedicate with steroid + antihistamine), peripheral neuropathy, myelosuppression, arthralgia, nail changes.
3 ยท Contraindications
Previous severe hypersensitivity (despite premedication), severe baseline neutropenia, and caution with strong CYP2C8/3A4 inhibitors; avoided in pregnancy.
4 ยท Indication
Ovarian, breast, lung and pancreatic cancers - requires premedication and monitored infusion.

Imatinib

Tyrosine kinase inhibitor (targeted therapy)
1 ยท Mechanism
Selectively inhibits BCR-ABL tyrosine kinase (plus c-KIT and PDGFR), switching off the constitutive signal driving chronic myeloid leukaemia cells.
2 ยท Adverse effect
Periorbital and generalised fluid retention, nausea, muscle cramps, myelosuppression, hepatotoxicity and rash.
3 ยท Contraindications
Pregnancy (embryo-toxic), and strong CYP3A4 inducers such as rifampicin crash its levels while inhibitors such as grapefruit raise them.
4 ยท Indication
Chronic myeloid leukaemia (transformed by the Philadelphia chromosome - once fatal, now a chronic disease) and gastrointestinal stromal tumours.

Azathioprine

Purine analogue immunosuppressant
1 ยท Mechanism
Converted to 6-mercaptopurine, a fraudulent purine that blocks de novo purine synthesis and lodges in DNA, starving proliferating lymphocytes.
2 ยท Adverse effect
Myelosuppression (dose-limiting - full blood counts), hepatotoxicity, pancreatitis, and hypersensitivity with fever and rash; infection risk.
3 ยท Contraindications
Thiopurine methyltransferase (TPMT) deficiency - fatal myelosuppression, so test first; and allopurinol triples its levels (huge dose reduction required).
4 ยท Indication
Transplant rejection prophylaxis, rheumatoid arthritis, inflammatory bowel disease and lupus.

Mycophenolate

IMPDH inhibitor (purine synthesis)
1 ยท Mechanism
Blocks inosine monophosphate dehydrogenase, the rate-limiting enzyme of de novo guanine synthesis - lymphocytes depend on this pathway uniquely.
2 ยท Adverse effect
Diarrhoea and GI upset (most common), myelosuppression, teratogenicity (first-trimester loss and malformations), increased infections and CMV reactivation.
3 ยท Contraindications
Pregnancy (absolute - effective contraception required), prior mycophenolate hypersensitivity, and no live vaccines during therapy.
4 ยท Indication
Organ transplant rejection prophylaxis, lupus nephritis and resistant glomerulonephritis.

Ciclosporin

Calcineurin inhibitor
1 ยท Mechanism
Binds cyclophilin, inhibiting calcineurin so NFAT cannot enter the nucleus - IL-2 transcription and T-cell activation are switched off.
2 ยท Adverse effect
Nephrotoxicity (both acute vasoconstriction and chronic fibrosis), hypertension, gingival hyperplasia, hirsutism, tremor, hyperlipidaemia, infection and lymphoma risk.
3 ยท Contraindications
Prior hypersensitivity, live vaccines during immunosuppression, and caution with nephrotoxic or CYP3A4-interacting drugs (levels are monitored).
4 ยท Indication
Transplant rejection prophylaxis, severe rheumatoid arthritis, psoriasis and atopic dermatitis (topical form).

Rituximab

Anti-CD20 monoclonal antibody
1 ยท Mechanism
Binds CD20 on pre-B and mature B cells, triggering complement and antibody-dependent cytotoxicity plus direct apoptosis - B-cell depletion.
2 ยท Adverse effect
Infusion reactions on first dose (premedicate), severe infections including hepatitis B reactivation, progressive multifocal leucoencephalopathy (rare), late neutropenia.
3 ยท Contraindications
Active serious infection, and hepatitis B screening before every course (reactivation risk); defer live vaccines; avoided in pregnancy unless essential.
4 ยท Indication
Rheumatoid arthritis, non-Hodgkin lymphoma, CLL, granulomatosis with polyangiitis and multiple sclerosis.

Allopurinol

Xanthine oxidase inhibitor (antigout)
1 ยท Mechanism
Its metabolite oxipurinol competitively and irreversibly inhibits xanthine oxidase, blocking conversion of hypoxanthine and xanthine to uric acid.
2 ยท Adverse effect
Rash (stop at first sign - can progress to severe cutaneous adverse reactions), hypersensitivity syndrome with fever, eosinophilia and hepatitis, and early gout flare.
3 ยท Contraindications
Acute gout flare (start only after it settles), prior allopurinol allergy or HLA-B*58:01 positivity (screen in high-risk Asian and African American patients), severe renal impairment.
4 ยท Indication
Chronic hyperuricaemia and recurrent gout prophylaxis (never during a flare) - also prevents uric acid crisis in tumour lysis syndrome.

Ferrous Sulfate

Iron supplement (ferrous salt)
1 ยท Mechanism
Supplies elemental iron as Fe2+ for haemoglobin synthesis, absorbed in the duodenum via DMT1 and boosted by ascorbate.
2 ยท Adverse effect
Black stools, constipation, nausea and epigastric pain - and acute ingestion in children causes vomiting then hepatotoxicity (the leading fatal poisoning in toddlers).
3 ยท Contraindications
Iron overload (haemochromatosis), concurrent tetracycline or antacids (chelation - separate doses), and active peptic ulcer disease.
4 ยท Indication
Iron-deficiency anaemia (oral first-line, parenteral if malabsorbed) - deferoxamine is the antidote in acute overdose.

Folic Acid

Vitamin (B9) supplement
1 ยท Mechanism
Reduced to tetrahydrofolate, the one-carbon donor required for thymidylate and purine synthesis and methylation reactions.
2 ยท Adverse effect
Very safe; rare hypersensitivity with injections - but high doses can mask vitamin B12 deficiency while irreversible neurological damage continues.
3 ยท Contraindications
Untreated B12 deficiency (relative - it corrects the anaemia and hides the deficiency, so check B12 first in megaloblastic anaemia).
4 ยท Indication
Periconceptional prevention of neural tube defects, folate-deficiency megaloblastic anaemia, and rescue in methotrexate toxicity.